Home Blog Page 124

Studies Show Effectiveness of Ursodeoxycolic Acid in Managing NAFLD

0

 

Several studies have validated the effectiveness of Ursodeoxycholic acid (UDCA), as an anti-apoptotic agent lowering serum TNF-α concentrations, decreasing endoplasmic reticulum stress and improving hepatic insulin sensitivity, suggesting that UDCA may be effective in the treatment of  non-alcoholic steatohepatitis (NASH).

Non-alcoholic fatty liver disease (NAFLD) is the term for a range of conditions caused by a build-up of fat in the liver in people without significant history of alcohol use/abuse. It’s usually seen in people who are overweight or obese, but can also be seen in persons with normal BMI.

As the name implies, the main characteristic of NAFLD is too much fat stored in liver cells. NAFLD  is one of the most common forms of chronic liver disease which may progress to NASH and eventually develops into cirrhosis or liver cancer.

The role of Ursodeoxycholic Acid in NAFLD

Sanjeev R. Mehta, in a research published on Therapeutic Advances in Endocrinology and Metabolism found that UDCA monotherapy significantly improved liver function in five studies and improved steatosis and fibrosis in two studies.

All five studies assessing UDCA combination therapy (especially with Vitamin E) showed significant improvements in liver function, while two studies also improved steatosis and inflammation.

One study of high-dose UDCA showed significant improvements in ALT, γGT and liver fibrosis, whereas the other study showed no significant change in ALT and liver pathology.

Another finding as published on pubmed.gov found that the combination of UDCA with vitamin E significantly improves liver function tests in long-term and is very well tolerated.

Studies Show Effectiveness of Ursodeoxycolic Acid in Managing NAFLD
Pharm. Makuo Muobike

 

NAFLD is said to be developed by a 2-hit hypothesis where the first hit is the presence of fat in the liver (Steatosis) and the second hit is the presence of free radicals capable of inducing oxidative stress.

A retrospective study published on BMC Gastroenterology  shows that 41 per cent of patients with NASH progressed to liver fibrosis and 5.4 per cent to end-stage liver diseases.

The systematic review of 224 articles according to the format of PRIMSA  revealed that the prevalence of NASH has increased with obesity and type 2 diabetes topping the list of conditions.

The lead investigators of the team Zun Xiang, Yi-peng Chen and Kui-fen Ma, assessed the study eligibility and methodological quality to ensure that no quality compromise exists in the research.

According to them, “despite the “two hit hypothesis” for NAFLD, the mechanism by which it progresses to NASH is still vague, but may include oxidative stress, free fatty acid induced lipotoxicity, mitochondrial dysfunction, endoplasmic reticulum stress, dysregulated cytokines and gut bacteria overgrowth.

“However, due to its yet undetermined pathogenesis, NASH therapy remains empirical and is limited to treating associated conditions, including diabetes, obesity and hyperlipidemia. The current standard of care in the treatment of NASH involves weight loss and increased physical activity, which, while useful in treating simple steatosis, is difficult for patients to achieve”, they stated.

There are four stages involved in the development of NAFLD. They are :

Simple fatty liver (steatosis) – occurs when there is a buildup of fat in the liver cells. This stage is mainly harmless, and is often diagnosed during tests carried out for another reason.

Non-alcoholic steatohepatitis (NASH) – A more serious form of NAFLD, where the fat globules in the liver cells cause inflammation of the liver. NASH occurs in about one quarter of patients with NAFLD.

Fibrosis – where continuous inflammation causes scarring of the tissue around the liver and nearby blood vessels.

Cirrhosis – the most severe stage, occurring after years of inflammation, where the liver shrinks and becomes scarred and lumpy; this damage is permanent and can lead to liver failure (where the liver stops working properly) and liver cancer.

In a chat with Pharm. Makuo Muobike, product manager, Mega Lifesciences Nigeria Ltd., marketers of Ursoliv, a brand of Ursodeoxycholic acid, he said clinical observations have revealed that NAFLD is seen in 80 per cent of patients with metabolic syndrome consisting of type II diabetes, obesity and hyperlipidaemia.

He stated further that being a secondary bile acid, produced by intestinal bacteria as metabolic byproduct, UDCA has shown to be effective in non-surgical treatment of cholesterol gallstones and primary biliary cholangitis (PBC).

“The clinical properties of UDCA are as follows: widely used in the treatment of patients with PBC, primary sclerosis cholangitis (PSC) and has an excellent safety profile”, he asserted.

 

Study Reveals South Africa COVID-19 Strain offers Immunity Against Other Variants

0

A new study has shown that people previously infected by the COVID-19 variant identified in South Africa have better immunity against other coronavirus mutations. 

The findings released on Wednesday, from preliminary research by the team of South African scientists who identified the variant dubbed 501Y.V2, raise hopes that vaccines modelled on the strain could protect against future mutations.

Identified late last year, the variant fuelled South Africa’s second wave of infection and delayed the start of vaccinations in February.

Scientists said on Wednesday that plasma collected from people infected with the variant had “good neutralising activity”, including against “first wave” viruses and potentially other variants of concern.

After the antibodies were tested against the original strain and another identified in Brazil, “results are showing a clear sense of direction”, virologist Tulio de Oliveira said in a video conference.

Health Minister Zweli Mkhize told the same meeting that the discovery was “good news for all” as it presented a huge boost to the control of the pandemic.

Coronavirus mutations – some more contagious – had put a damper on global vaccination programmes after existing shots were found to offer less protection against them.

Manufacturers have in recent weeks raced to tweak their formulas in response to the spread of newer variants.

(AFP)

Taking Fruits Twice, Vegetables Thrice a Week Elongates Life – Study

1

Several studies have proven that fruits and vegetables are critical to promoting good health. In fact, fruits and vegetables should be the foundation of a healthy diet. Most people need to double the amount of fruits and vegetables they eat every day to enjoy long life.

A study conducted by Imperial College London (ICL) and Harvard scientists has shed more light on taking of fruits twice and vegetables thrice a week, they found that it could prevent not just 7.8 million premature deaths each year but also lower risk of disease and prevention of early death.

Scientific evidence indicates that frequent consumption of fruits and vegetables can prevent oesophageal, stomach, pancreatic, bladder and cervical cancers and that a diet high in fruits and vegetables could prevent 20 per cent of most types of cancers.

Common fruits and veggeies that are likely to boost your immune system

After analysing more than 2 million adults worldwide, Harvard scientists reported that our five-a-day should be made up of two fruits and three vegetables for a longer life.

“While groups like the American Heart Association recommend four to five servings each of fruits and vegetables daily, consumers likely get inconsistent messages about what defines optimal daily intake of fruits and vegetables such as the recommended amount, and which foods to include and avoid,” said lead author Dr Dong Wang.

In the UK, NHS guidelines state that 80g of fresh, canned or frozen fruits and vegetables count as one portion of someone’s five-a-day. People can also up their quota with 30g of dried fruit.

Juice and smoothies also count up to 150ml a day, with any more raising the risk of tooth damage from the natural sugars released during the crushing process.

While it may sound an easy enough target to hit, less than a third (28 per cent) of adults in the UK got their five-a-day in 2018, with the average Briton consuming just 3.7 portions.

To better understand the optimal fruit and vegetable intake, the Harvard scientists analysed the diets of more than 2 million people from numerous studies.

Results, published in the journal Circulation, reveal eating around two servings of fruit and three portions of vegetables a day was associated with the greatest longevity.

“This amount likely offers the most benefit in terms of prevention of major chronic disease and is a relatively achievable intake for the general public,” said Dr Wang.

Nevertheless, eating five servings of fruits and vegetables a day – whatever the produce consumed – was linked to a lower risk of premature death.

Hitting the five-a-day target was associated with a 13 per cent lower premature death risk from any cause, compared to managing just two fruit or vegetable servings a day.

The death risk from heart disease, cancer or a respiratory disorder, like chronic obstructive pulmonary disease, went down 12 per cent, 10 per cent and 35 per cent, respectively.

Consuming more than five servings was not associated with additional longevity benefits, however.

The results further suggest not all fruits and vegetables are created equal.

Starchy produce, like peas and corn, as well as fruit juices and potatoes, were not associated with a reduced risk of premature death from any cause.

These benefits were most pronounced among green leafy vegetables, like spinach, lettuce and kale.

A high intake of produce rich in the antioxidant beta carotene and vitamin C – like citrus fruits, berries and carrots – were also shown to cut the participants’ premature death risk.

“We found not all fruits and vegetables offer the same degree of benefit, even though current dietary recommendations generally treat all types of fruits and vegetables, including starchy vegetables, fruit juices and potatoes, the same,” said Dr Wang.

The research was observational, and therefore does not prove cause and effect.

“The American Heart Association recommends filling at least half your plate with fruits and vegetables at each meal,” said Dr Anne Thorndike, chair of the association’s nutrition committee.

“This research provides strong evidence for the lifelong benefits of eating fruits and vegetables, and suggests a goal amount to consume daily for ideal health.

“Fruits and vegetables are naturally packaged sources of nutrients that can be included in most meals and snacks, and they are essential for keeping our hearts and bodies healthy.”

 

 

Researchers Stop Trials of Plasma Transfusions for COVID-19 Patients

0

United States health researchers said on Tuesday they are halting clinical trials of convalescent blood plasma in patients with mild to moderate COVID-19 symptoms after preliminary results showed no benefit from the treatment.

The trial that began in August involved just over 500 people who went to emergency rooms but did not need to be hospitalised.

The people chosen for the study also had risk factors such as obesity, high blood pressure, diabetes or heart trouble.

Some of them received the treatment – blood plasma from people who had COVID and overcame it – and others got a placebo.

Researchers Stop Trials of Plasma Transfusions for COVID-19 Patients
Researchers Stop Trials of Plasma Transfusions for COVID-19 Patients

Doctors looked at how many needed additional care or outright hospitalisation, or who died, in the 15 days after undergoing the treatment.

An independent group of experts determined that while the convalescent plasma intervention caused no harm, it was unlikely to benefit patients, the National Institutes of Health said.

Convalescent plasma is the liquid part of the blood from a COVID-19 patient that recovered. It contains antibodies produced by the body after being infected.

In late October a study carried out in India and published in the medical journal BMJ said the treatment offered limited effectiveness.

It did not reduce mortality or keep people with moderate COVID symptoms from developing a serious case.

More than 100,000 people have received the treatment in the US since the start of the pandemic and many more elsewhere in the world, the NIH said.

In late August, at the persistent request of then-president Donald Trump, the US Food and Drug Administration granted emergency authorisation for transfusions of blood plasma from recovered COVID patients to people who were hospitalised with the disease.

The then head of the FDA, Stephen Hahn, acknowledged an error at a press conference with Trump, saying he had cited figures that overestimated the benefits of the treatment.

The FDA recently restricted its emergency authorization to use of plasma only with a high concentration of antibodies and for patients hospitalised with early stages of COVID or with a limited ability to produce antibodies.

(AFP)

What do you understand calcium channel blockers?

9

The following statements concerning mechanism of calcium channel blockers’ action are true, EXCEPT:

a) Therapeutically active agents in this group are capable of releasing nitric oxide (NO) in vascular smooth muscle target tissues

b) Calcium channel blockers bind to L-type calcium channel sites

c) Calcium channel blockers useful in angina decrease myocardial oxygen requirement (by decreasing the determinations of oxygen demand) and increase myocardial oxygen delivery (by reversing coronary arterial spasm)

d) Calcium channel blockers decrease transmembrane calcium current associated in smooth muscle with long-lasting relaxation and in a cardiac muscle with a reduction in contractility

Mareek Image Concepts Presents Achievers Forum 2021

0

Mareek, the organiser of Achievers Forum seminar is excited to inform the general public that this year event will come up March 19-21, 2021, with the theme, “New World,  New You, New Possibilities”.

The details of the event are as follow:

Conference objectives

At the end of the 3-day events, participants will:

  1. Learn disruptive strategies to survive and thrive in our new world.
  2. Be equipped on how to fast track their leadership journey to succeed in our new normal.
  3. Be challenged to develop the flux culture that will support growth and happiness in our ever-changing world.

Date: March 19-21, 2021.

Time: 7pm – 9 pm daily.

Venue: Zoom and Facebook

Meet Our Facilitators

Lere Baale is a Professor and Chief Executive of Business School Netherlands International, Nigeria and also Regional Partner of HOWES – CMOE Inc. USA inAfrica & Middle East Area. Described as a result oriented Transformational Leader who inspires world class leaders to take action even in chaos to achieve results through resilience. A strong believer that opportunities are usually wrapped as challenging impossibilities. Served the pioneering Governing Management Board of a University Teaching Hospital 2008-2016.He has business transformation experience in leading world class global firms including – Pfizer Worldwide Biopharmaceuticals, Mike Adenuga Group, BSN & CMOE-USA. At Pfizer, he served as Executive Regional Director rebuilding Pfizer afresh from ground zero in 1997 to cover over 32 countries by 2004.

He is a Professor of Organization Transformation in Business School Netherlands, Director of World Institute of Action Learning Coaches in Nigeria. He is Board Member of Haggai Leadership International Alumni. a Chartered President of Toastmaster, President of Entrepreneurs Organization 2019-2020 & a member of Ikoyi Club 1938. He will be facilitating the strategy session with the topic, ” New Disruptive Interventions In Crisis Management: Turning Your Challenges To Possibilities In The next 100 Days.” A one hour session strategy session with Prof. Lere Baale worth $2,000.

Dr Dayo Olomu, Chair, CIPD South London; Chair, Black on Board Community UK;  Board Member at Southwark Diocesan Board of Education is a renowned international motivational speaker, human capital development expert, corporate trainer, business mentor, executive coach,  bestselling author, mindfulness enthusiast,  mental health champion and keynote speaker.

A holder of 160 awards in 25 categories, he holds an honours degree in Business Information Systems, MSc in Human Resources and an honorary doctorate. He has a Diploma in Coaching, an Advance Certificate in Public Relations and a Post-Graduate Certificate in Further Education. He is a Chartered Member of the Chartered Institute of Personnel Development (CIPD), Fellow of the Institute of Information Management Africa (IIM) and Member, International Leadership Association. Dr Dayo Olomu, based in London, United Kingdom will be facilitating the leadership session with the topic, “Fast Tracking Your Leadership Journey in the Next 100 Days to Thrive in our New World” A one hour session with Dr Dayo Olomu worth £1,500 .

Sesan Kareem is the Founder and Chief Strategist of Mareek Image Concepts and also the Principal Consultant of Sesan Kareem Institute for Life Engineering (SKILE). As a coach, speaker, author, consultant, and trainer, Sesan helps leaders and business entities around the country to instill within them not just the belief system to succeed and motivation to excel, but also actionable strategies that will help them to grow, improve and thrive in our ever-changing world.

He is a UK-published, EU-copyrighted and Amazon-marketed Author who has written 7 life-transforming books on personal development and life mastery. He is being regarded as one of the most provocative African speakers/trainers of contemporary age. He holds a Bachelor of Pharmacy from Olabisi Onabanjo University (OOU) and International Award in Delivering Training (IADT) from Highfield Award Body for Compliance (HABC), United Kingdom and Master in Public Administration with bias for Human Resources Management and services from UNILAG. He serves as a board member of HAVEK Leadership Academy, Safe Medicines Foundation, Mareek Image Concepts and EMQ Trials, Nigeria.

A wellness and healthy living facilitator of Industrial Training Fund, who has trained staff of Nestle, MTN, FCMB, Greenlife Pharma, New heights Pharma just to name a few. He is a columnist in Pharmanews- Nigeria’s leading Health Journal (Published since 1979). He is the convener, Achievers Business Forum, It’s In You and “Motivating the Nigerian Youth” a movement that has trained over 4,000 young Nigerians for FREE. He will be facilitating a session on the topic, “Developing a Flux Culture to Support Your Growth in the Next 100 Days.” A one hour personal growth session with Sesan Kareem worth $500.

 Investment

Regular: N2, 000 ($5) for Early Bird.

Registration fee covers 

  1. Training fee for the 3 days session
  2. Digital tool titled “Truths and Myths about Money: What School Will Not Teach You About Financial Intelligence.” worth N2000 ($5)
  3. Training materials (Slides and Daily assessment tools)

Premium: N20,000 ($50) for Early Bird.

Registration fee covers 

  1. Training fee for the 3 days session
  2. 5 Digital tools that worth N20,000 ($50)
  3. Training materials (Slides and Daily assessment tools)
  4. One hour special Q & A session with ALL facilitators.
  5. Free 100 days coaching with Mareek Image Concepts.

Early Bird closes on March 14, 2021.

 Money Back Guarantee!

If you are not SATISFIED with your experience during the seminar. Let us know after the first one hour of Day 1 and we will refund you.

Limited seats available based on first come first served.

Register now, through this link,

https://selar.co/Achievers

For any enquiry, talk to us on, 08145260735

Announcer

Ebere Ogbonna

For Mareek Image Concepts

 

 

Nigeria, Two Others Top List of Free COVAX Vaccine Beneficiaries

0

Nigeria, Pakistan and Indonesia will be among the biggest recipients of free COVID-19 vaccines before June — more than 10 million doses each — the COVAX scheme announced Tuesday.

Some 238.2 million doses will be distributed around the world by the end of May through the programme aimed at boosting access to coronavirus vaccines in poorer nations.

Though vaccination campaigns have gathered pace globally, the majority of injections have been administered in wealthier countries while many nations have yet to receive a single dose.

PHOTO: Twitter

The COVAX scheme, aimed ensuring equitable access to COVID-19 vaccines, on Tuesday outlined plans to deliver to 142 countries and territories by May 31, in its first wave of distribution.

The five biggest confirmed recipients are Pakistan (14,640,000 doses), Nigeria (13,656,000), Indonesia (11,704,800), Bangladesh (10,908,000) and Brazil (9,122,400).

They are followed by Ethiopia (7,620,000), the Democratic Republic of the Congo (5,928,000), Mexico (5,532,000), Egypt (4,389,600) and Vietnam (4,176,000).

Iran, Myanmar, Kenya and Uganda are also in line for more than three million doses each.

Overall by the end of May, India is likely to be the biggest recipient of COVAX doses, but its allocation was not finalised before the publication of the distribution list on Tuesday.

The Pacific island nation of Tuvalu is, meanwhile, set to receive the smallest number of doses at 4,800, followed by Nauru and Monaco with 7,200 each.

COVAX is co-led by the World Health Organisation, the Gavi vaccine alliance, and the Coalition for Epidemic Preparedness Innovations, CEPI.

The scheme is aiming to distribute enough doses to vaccinate up to 27 percent of the population in the 92 poorest participating economies by the end of the year, with at least 1.3 billion doses intended to go their way.

“COVAX’s mission is to help end the acute phase of the pandemic as soon as possible,” said Gavi chief executive Seth Berkley.

The first wave of deliveries include some 237 million doses of the AstraZeneca/Oxford vaccine, being manufactured in India and South Korea, and another 1.2 million doses of the Pfizer/BioNTech vaccine, which requires special ultra-cold storage.

Both vaccines require two injected doses.

Ghana, Ivory Coast, South Korea, India and Colombia have already received their first deliveries of vaccines through COVAX.

Nigeria, Angola, Cambodia all received their first vaccine doses via COVAX on Tuesday, with the DR Congo also scheduled for a delivery.

Senegal was set to get its first batch on Wednesday, and some 20 countries in total are due to receive shipments this week.

Ghana received the first flight of COVAX AstraZeneca doses on February 24 — and President Nana Akufo-Addo publically took the first vaccination on Monday.

He said on Tuesday that it was “imperative” that Africa develops its own vaccine production capacity to facilitate easy and affordable access to doses.

The African Union Commission will host a meeting on April 12 aimed at developing a roadmap for the continent to start manufacturing COVID-19 vaccines.

Some 198 countries and territories are participating in COVAX, though not all are in the first wave of distribution.

For the 92 lower- and lower-middle income economies in the scheme, funding is covered through donations.

For richer countries, buying into COVAX’s bulk purchases operates like a back-up insurance policy for their own direct deals with vaccine producers.

Some wealthy countries were on the distribution list, with South Korea in line for 2.2 million doses, Canada 1.6 million, Saudi Arabia 1.5 million, Singapore 245,000 and New Zealand 211,000.

Any vaccine being rolled out through COVAX requires the WHO seal of approval — so far given to just the Pfizer and AstraZeneca vaccines.

Novavax will provide 1.1 billion COVID-19 vaccine doses to COVAX, while the facility has also signed deals with Sanofi-GSK, and with Johnson & Johnson.

(AFP)

COVID-19 Health Workers Subjected to Over 400 Acts of Violence in 2020 –Report

2

Insults, beatings, arrests – health workers battling the coronavirus were subjected to more than 400 acts of violence related to COVID-19 worldwide in 2020, according to a report published on Tuesday by a health Non- Governmental Organisation.

The Safeguarding Health in Conflict Coalition unveiled an interactive map that shows 1,172 violent acts and attacks occurred against health workers or facilities last year, “a minimum estimate,” according to the NGO.

Health workers in mask while fighting the disease

More than a third (412) of the acts are directly related to COVID-19, it said, citing several examples including in Mexico, where a nurse was attacked and injured by a group accusing her of spreading the virus.

In Dakar, three social workers had stones hurled at them by residents who refused to have a coronavirus victim buried near their homes.

In Birmingham, England, a health worker was spat at and insulted by a neighbour.

The vast majority, 80 percent, of the perpetrators of the violence were civilians, but threats also came from public authorities.

In Egypt, health workers who criticized the regime’s handling of the pandemic were arrested by security forces and accused of spreading false information and of belonging to a terrorist group

Insecurity Insight, which developed the interactive map, also recorded 802 attacks in countries at war or on victims of civil conflicts, such as the bombing of hospitals in Yemen and the kidnapping of doctors in Nigeria.

“The map shows that violence and intimidation against health care was a truly global crisis in 2020, affecting 79 countries,” said Insecurity Insight director Christina Wille in a statement.

Leonard Rubenstein, the president and founder of the Safeguarding Health in Conflict Coalition and a professor at Johns Hopkins University, called on international governments to protect health workers, including by fighting disinformation.

(AFP)

All of the following are normally involved in the pathogenesis of heart failure EXCEPT:

5

All of the following are normally involved in the pathogenesis of heart failure EXCEPT:

a) A cardiac lesion that impairs cardiac output

b) An increase in peripheral vascular resistance

c) A decrease in preload

d) An increase in sodium and water retention

BREAKING NEWS: Astrazeneca Vaccines Arrive Nigeria

2

The National Primary Healthcare Development Agency (NPHCDA) has announced that the first batch of AstraZeneca vaccines has arrived Nigeria from the COVAX Facility and will be deployed to vaccinate.

In a series of tweets via the Agency’s verified Twitter handle @NphcdaNG, the Minister of Health yesterday, Dr Osagie Ehanire, disclosed they were expecting the arrival of 3.92 million vaccines today.

The aircraft containing the vaccines arriving Nigeria

He said that the vaccines that are not approved by NAFDAC will be determined as dangerous, and will be seized by Customs Services and NAFDAC, who are on high alert for illegal vaccine importation.

“No private hospital or organisation has experience with handling this type of vaccine and certainly no experience in vaccine application that NPHCDA has.

“The introduction of the electronic management of immunisation data is critical to addressing challenges with integrity and quality data and ultimately, primary healthcare data, he added.”

The National Primary Health Care Development Agency, NPHCDA, also released guidelines on registering for Covid-19 vaccination in Nigeria.

The guidelines were announced Monday morning in a social media post and they are as follows

Step 1: Visit https://nphcda.gov.ng/

Step 2: Click on” covid-19 vaccination e-registration”

  • In the Registration Form for COVID-19 Vaccination you are to fill in; your full names, phone number, email address, date of birth, sex, the type of National ID you have, a residential address which states, the LGA of residence, ward of residence and preferred vaccination site.
  • You are meant to also select your preferred vaccination date and time slot, which ends with a photo update.
  • After doing the above steps, you will receive a message saying:
  • “Registration Completed! …Your Vaccination ID is:
  • Your data is successfully received.
  • Thank you for taking time to fill the form, you will receive an SMS and email shortly containing your Vaccination No. and other instructions.”

 

 

 

 

NPHCDA Unveils Portal for COVID-19 Vaccination e-Registration

0

– As pharmacists alleged exclusion from list

NPHCDA Unveils Portal for COVID-19 Vaccination e-Registration
COVID-19 vaccine illustration by the NPHCDA

 

The National Primary Healthcare Development Agency (NPHCDA) on Monday launched a portal for the e-registration of Nigerians for the COVID-19 vaccination, ahead of vaccine arrival in less than 24 hours.

This is even as some pharmacists have alleged the omission of pharmacists from the lists of healthcare workers to benefit from the first phase of vaccination.

In a statement announcing the introduction of the portal, Chief Executive Officer, NPHCDA, Dr Faisal Shuaib explained the objective of the platform is to make registration for COVID-19 vaccination easy for citizens.

While inviting citizens to website the Agency’s website to access the e-registration portal, he said Nigerians can choose a health facility that is closest to them to get vaccinated.

Explaining the various phases of the vaccination, he noted that the first phase of the vaccination, will prioritised healthcare workers, frontline workers — (the Military, Police, Oil and Gas workers, Nigerians at the Border Posts), strategic leaders and vulnerables.

“Please visit our website http://nphcda.gov.ng and click on ‘COVID-19 Vaccination e-registration’ to register for #COVID19 vaccination”, he urged Nigerians.

In a series of tweets via the Agency’s verified Twitter handle @NphcdaNG, the Minister of Health, Dr Osagie Ehanire reiterated the expected arrival of 3.92 million vaccines in less than 24 hours in the country.

Ehanire who hinted that officials of Customs and NAFDAC are on the look out for unauthenticated vaccines, noted that any vaccine that is not approved by NAFDAC will be confiscated.21.

“In less than 24 hours, the first batch of AstraZeneca vaccines will arrive in Nigeria from the COVAX Facility & will be deployed to vaccinate, first our critical frontline healthcare workers, who are providing essential care.

“Vaccines that are not approved by NAFDAC will be determined as dangerous, and will be seized by Customs Services and NAFDAC, who are on high alert for illegal vaccine importation.

“No private hospital or organisation has experience with handling this type of vaccine and certainly no experience in vaccine application that NPHCDA has.

“The introduction of the electronic management of immunisation data is critical to addressing challenges with integrity and quality data and ultimately, primary healthcare data”, he stated.

Earlier in the day, some pharmacists on Twitter have queried the omission of pharmacists from the list of frontline healthcare workers to benefit from the first phase of the vaccination.

@Swankpharm was the first to raise the concern tweeting thus: “Dear @NphcdaNG kindly confirm if pharmacists as frontline healthcare providers were omitted knowingly or unknowingly from the list of healthcare providers scheduled to register for the #COVID19 vaccine?”.

Reacting to the development, Pharm. Isa Muhammad with his Twitter handle @isacisse said:” It’s deliberate and must be amended”.

In its response to the pharmacists questions on omission, the NPHCDA through one of its officials with the Twitter handle @chibuezze acknowledged the pharmacists’ place in the healthcare system, stating that the omission has been rectified.

His tweet reads:” You’d agree with me that pharmacists have been very integral in this fight to not just be classifed as just “Health Worker”.
“It’s been updated nonetheless. There’s an option for pharmacists now!”.

 

 

Medical Myths about Heart Disease

0

Sometimes it can be hard to separate fact from fiction, especially when so many of the “facts” we’ve spent our whole lives believing are actually enduring myths and misconceptions. These common myths seem true because we’ve heard them time and time again—we may have even learned them from our parents, or been taught them at school.

Nevertheless, it’s more important than ever to call out the false facts that far too many people still believe, whether they’re related to our furry friends or the current pandemic. Read on to discover the truth behind some of the most persistent common myths surrounding heart disease.

This topic will focus its beams on the many half-truths and misconceptions that surround heart disease. Among other topics, we cover smoking, coughing, exercising, supplements, and statins.

Globally, heart disease is the number one cause of death. It is responsible for 17.9 million deaths each year.

Medical Myths about Heart Disease
Medical Myths about Heart Disease

According to the Centres for Disease Control and Prevention (CDC), in the United States, one person dies every 36 seconds from cardiovascular disease. Heart disease accounts for 1 in 4 deaths in the U.S.

According to the findings published on medicalnewstoday, listed below are the most common myths about heart failure:

Myth 1: Young people do not need to worry about heart disease

It is true that heart disease is more likely to affect people over the age of 65, but 4–10 per cent of heart attacks occur in people under the age of 45 years, mainly in men. In addition, it is how we live our lives as children, adolescents, and adults that lays the groundwork for heart health as we age.

For instance, eating a diet that is high in Trans and saturated fats or smoking tobacco slowly increases the risk of heart disease as we age. Changes to lifestyle today build the foundation for a healthier heart in later life.

In the U.S. as a whole, heart disease mortality has slowly dropped since the 1970s, although the trend seems to be slowing. However, in some regions, rates have increased.

One study that investigated heart disease mortality in different age groups in the U.S. found that “over 50 per cent of counties [experienced] increases in heart disease mortality from 2010 through 2015 among adults aged 35–64 years.”

Myth 2: People should not indulge in exercise if they have heart disease

This is a myth. Exercise helps strengthen the heart muscle and improve blood flow around the body.

In August 2020, the European Society of Cardiology published guidelines on exercise in patients with cardiovascular disease. Prof. Sanjay Sharma, who was involved in creating the guidelines, explains:

“The chance of exercise triggering a cardiac arrest or heart attack is extremely low.” However, he also adds a note of caution: “People who are completely inactive and those with advanced heart disease should consult their doctor before taking up sports.”

Myth 3: Because I take cholesterol-lowering drugs, so I can eat whatever I like

Some drugs, such as statins, reduce the level of cholesterol in the blood. However, this does not mean that a person who is taking statins can consume foods containing saturated fats with abandon.

Cholesterol is either consumed in the food that you eat or produced in the liver. Statins block an enzyme in the liver that is necessary for producing cholesterol, reducing overall blood cholesterol levels. However, this means that ingested cholesterol can still make it into the blood.

In short, statins may just be able to override the adverse effects of a poor diet, but a poor diet will increase risk of other independent risk factors for heart disease, such as obesity, hypertension, and diabetes.

Myth 4: Heart disease runs in my family, so I can’t do anything to increase my heart’s health.

If close family members have experienced heart disease, it could mean that you have an increased risk. However, it is not set in stone, and there are a number of ways to reduce the risk, even for people with a genetic susceptibility.

These include eating a healthful diet, stopping smoking, managing blood pressure, and exercising regularly.

It is also worth noting that if heart disease runs in the family, it may not be a sign of genetic susceptibility. Families tend to share lifestyle factors, such as diet and exercise habits, both of which can impact the risk of heart disease.

Actually, you can do many things to help your heart’s health! Moderate exercise a few times a week, eating a healthy diet that’s low in fatty foods and cholesterol, and maintaining a healthy weight are all within your control and can help your heart to be healthier even though you’re at risk for heart disease. Just as importantly, if you’re a smoker, the sooner you stop smoking the better it is for your heart and your overall health.

Myth 5: My heart is beating very fast. This is certainly heart attack.

Your heart rate increases with moderate to strenuous exercise – even after walking briskly up a few flights of stairs! You may also feel as if your heart is “racing” after having too much caffeine. And sometimes people experience palpitations or an irregular heartbeat, called an arrhythmia, once in a while. This is not a cause for concern unless it’s very frequent and affects how well your heart works. If this is the case, you should see a cardiologist for treatment.

Myth 6: Vitamins is likely to prevent heart disease

Although most vitamins, taken at the recommended doses, are unlikely to be bad for heart health, there is no evidence that taking any vitamin supplements can reduce the risk of heart disease. And they certainly cannot replace a healthful diet and regular exercise.

For instance, a systematic review and meta-analysis looked for associations between multivitamin and mineral supplements and a number of cardiovascular outcomes, including coronary heart disease and stroke.

The analysis, published in 2018, took data from 18 existing studies, including 2,019,862 participants.

The authors concluded that multivitamin and mineral “supplementation does not improve cardiovascular outcomes in the general population.”

According to Victoria Taylor, the nutrition lead at the British Heart Foundation: “There are no shortcuts when it comes to nutrition — supplements are not a replacement for healthy food. You might be prescribed a vitamin or mineral supplement by a health professional for other reasons, but we do not recommend people take multivitamins to help prevent heart and circulatory diseases.”

Myth 7: Smoking is my habit, and it’s been for years, there is no point stopping now

This is a myth. Smoking tobacco is a major cause of heart disease. As soon as a person stops smoking, the health benefits begin. The National Institute on Aging write:

“It doesn’t matter how old you are or how long you’ve been smoking, quitting smoking at any time improves your health. When you quit, you are likely to add years to your life, breathe more easily, have more energy, and save money.”

They also explain that you will lower the risk of heart attack and stroke and have better circulation.

Myth 8: Heart disease only affects men, women are left out

This is a myth, as heart disease is the leading cause of death in both men and women. In 2017 in the U.S., 24.2 per cent of men and 21.8 per cent of women died from heart disease.

However, when strokes, which have similar risk factors, are added in, the figures are even more similar between men and women: 28.7 per cent of men and 28 per cent of women died from heart disease or stroke.

It is a common misconception that only men are affected by heart disease. It is true that men tend to develop cardiovascular disease at an earlier age than women and have a greater risk of coronary heart disease. However, women have a higher risk of stroke.

One paper explains, “Although the incidence of [cardiovascular disease] in women is usually lower than in men, women have a higher mortality and worse prognosis after acute cardiovascular events.”

 

 

Applause as Obideyi Bows Out of ACPN Leadership

2

…As Ekhator Takes Over from Obideyi

It was an exciting moment at the indoor hall of the Pharmaceutical Society of Nigeria (PSN), Lagos Chapter, Ogudu, Lagos, as Pharm. Olabanji Benedict Obideyi, chairman, Association of Community Pharmacists of Nigeria (ACPN) Lagos Chapter, hands over the mantle of power, while recalling the challenges and successes encountered during his three years of service to the ACPN, Lagos State as the chairman.

Pharm. Obideyi, in an interview with Pharmanews recalled how he became a member of the executive in 2012, saying he had been secretary, vice-chairman, as well as chairman in the last nine years. “I had seen a lot, the challenges, the achievement, as well as the lapses, so I want to encourage the new leadership to hit the ground running”.

L-R Jonah Omonajoona Okotie, the immediate past secretary, Pharm. Olabanji Benedict Obideyi, chairman, and Pharm. Lawrence Ekhator, new elected chairman.

Acknowledging the support of the executive members of the outgoing administration, Obideyi, said the administration was unable to fulfill all its pre-election promises, due to some unforeseen challenges, but noted that the administration has improved the association despite constraints.

He however advised the newly elected executives to continue from where they stopped, and take the association to the next level. “I would want them to continue in unity and oneness and carry everybody along,” he advised.

Speaking on the issue of the National Agency for Food and Drug Administration and Control (NAFDAC), demanding money before destroying expired drugs, the immediate past ACPN boss condemned the action, adding that the development is ‘absurd’, as it was against the global best practice as obtainable in the advanced countries of the world.

Obideyi described the development as “double jeopardy” as pharmacists in Nigeria were made to pay before destroying their expired products, saying in the United States, UK, South Africa, including Ghana, those who submit expired products are compensated and encouraged to continue doing so for the safety of society.

Speaking in the same vein, the Chairman, Pharmaceutical Society of Nigeria (PSN), Lagos State Chapter, Pharm. Gbolagade Iyiola, expressed his worries over the situation, saying pharmacists incur loss of funds invested into their business, despite being charged for registration of those drugs by the regulators, adding that paying to the products destroyed is a loss to those concerned.

“What we are saying is this, it is not ideal for individual pharmacists to be destroying expired products on their own. The disposal of expired products should be done by the regulator. This is simply because these drugs are chemicals and they will have an impact on the environment and that is why it is ideal for the regulator to be in charge of it, but unfortunately, you will have to be at their mercy to get that done”.

The high point of the programme was the election of new executive members of the association for the next three years, which is renewable every year.

The newly elected executives of the association are Pharm. Lawrence Ekhator, chairman; Pharm. Paul Owolabi, vice-chairman; Pharm. Charles Oyeniyi, general secretary; Pharm. Mosunmola Dosumu, assistant general secretary; Pharm. Tolulope Ajayi, treasurer; Pharm. Moyinoluwa Oshin, publicity secretary; and Pharm. Olabanji Obideyi,  as the immediate past chairman.

In a sober reflection of what lies ahead of the association, the new chairman, Pharm. Lawrence Ekhator appealed to all members of ACPN across the state to work together with the new leadership, so as to take the association to the next level.

“The people should expect more engagement from us to the public whom we serve, that one is basic. We will try as much as possible to collaborate with the public because no matter how much we do if the public doesn’t know, we are like winking in the dark. So, what we intend to do is to make the public know more of who community pharmacists are, what we do, and what the public stands to benefit from engaging community pharmacists when it comes to issue of drugs,” he said.

He continued, as we all know, without drugs in healthcare, there is nothing left because drugs actually are the fulcrum of any healthcare industry. We will continue to engage the public, letting them know the importance of getting the right drug from the right people.

 

 

COVID-19 Vaccine Acceptance Rises in Some Countries –Study

2

Willingness to get a COVID-19 vaccine is on the rise compared to last year, a survey of six industrialised countries published on Monday showed.

More people in the United Kingdom, the United States and even vaccine-sceptical France now accept the idea of getting a coronavirus jab, KekstCNC, an international consultancy, said in the survey conducted in February.

The survey also covered Germany, Japan and Sweden where a similar trend was clear, it said.

“As vaccine rollouts commence, higher numbers of people in all countries say they would take the vaccine,” the study said.

This is a young woman receiving vaccine from a nurse.
Vaccinations are most often given via the intramuscular route in the deltoid or thigh muscle, to optimize the immune response of the vaccine and reduce the adverse reactions in and around the injection site.

The highest percentage was found in the UK with 89 per cent of those questioned in favour of taking a vaccine, up from 70 per cent in December.

In Sweden, the rate was 76 per cent against 53 in December, in the US 64 per cent against 58, in Germany 73 against 63 and in Japan 64 against 50.

France was the country in the study with the least enthusiasm at 59 per cent, but favourable opinions about vaccines were still sharply up from the 40 per cent level seen in December.

Some people were, meanwhile, highly critical of the vaccine rollout in their country.

While 76 per cent of Britons surveyed felt their government had gotten the rollout speed “about right”, that percentage fell to 32 per cent in the US, 28 per cent in Germany and Japan, 22 in France and only 20 per cent in Sweden.

People in the six countries judged that Israel and Britain had done the world’s best jobs with their vaccine rollout.

The novel coronavirus has killed at least 2,526,075 people since it emerged in China in December 2019, according to an AFP tally compiled from official sources on Sunday.

The United States is the worst-affected country with 511,998 deaths.

(AFP)

9,676 New COVID-19 Deaths, 421,848 Fresh Infections Recorded Globally

0

The novel coronavirus has killed at least 2,518,080 people since the outbreak emerged in China in December 2019, according to a tally from official sources compiled by AFP at 1100 GMT on Saturday.

At least 113,374,410 cases of coronavirus have been registered. Of these, at least 69,506,100 are now considered recovered.

These figures are based on daily tolls provided by health authorities in each country and exclude later re-evaluations by statistical organisations, as has happened in Russia, Spain and Britain.

On Friday, 9,676 new deaths and 421,848 new cases were recorded worldwide.

Based on latest reports, the countries with the most new deaths were United States with 2,046 new deaths, followed by Brazil with 1,337 and Mexico with 782.

The United States is the worst-affected country with 510,467 deaths from 28,486,575 cases.

After the US, the hardest-hit countries are Brazil with 252,835 deaths from 10,455,630 cases, Mexico with 184,474 deaths from 2,076,882 cases, India with 156,938 deaths from 11,079,979 cases, and Britain with 122,415 deaths from 4,163,085 cases.

The country with the highest number of deaths compared to its population is Belgium with 190 fatalities per 100,000 inhabitants, followed by Czech Republic with 189, Slovenia 184, Britain 180 and Italy 161.

Europe overall has 848,583 deaths from 37,377,892 cases, Latin America and the Caribbean 673,866 deaths from 21,221,851 infections, and the United States and Canada 532,372 deaths from 29,346,951 cases.

Asia has reported 255,413 deaths from 16,079,068 cases, the Middle East 103,754 deaths from 5,435,948 cases, Africa 103,143 deaths from 3,880,372 cases, and Oceania 949 deaths from 32,336 cases.

Since the start of the pandemic, the number of tests conducted has greatly increased while testing and reporting techniques have improved, leading to a rise in reported cases.

However, the number of diagnosed cases is only a part of the real total number of infections as a significant number of less serious or asymptomatic cases always remain undetected.

As a result of corrections by national authorities or late publication of data, the figures updated over the past 24 hours may not correspond exactly to the previous day’s tallies.

(AFP)

‘Vaccinating 27% Through COVAX, 20% Through Others will not get Africa 70% Herd Immunity’

0

The West Africa Health Organisation says that vaccinating 27 per cent of the population through the COVAX vaccine donation, and another 20 per cent through others will not get the content the 60 to 70 per cent desired herd immunity.

WACO says it will set up a coronavirus vaccine revolving fund in West Africa to ensure more funding for vaccination in the region.

Coronavirus

The Director General of WAHO, Prof. Standley Okolo, stated this on Friday in Abuja at an event to hand over critical medical materials to the Economic Community of West African States.

The News Agency of Nigeria reports that the handover event was organised by the Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH on behalf of the German Government and the European Union.

Okolo said that the revolving fund will provide technical cooperation to national immunisation programmes and to improve the region’s COVID-19 vaccine demands, planning and forecasting capacity.

He added that the fund will also strengthen supply chain management and ensure financing and sustainability.

“We are looking forward to setting up a vaccine revolving fund. As you all know, there will always be a deficit in terms of the coverage of our population with the COVID-19 vaccine and that is why the heads of state decided that we should set up the fund.

“When established, heads of state will ask governments to contribute, invite partners to contribute, including indigenous private sector and use a multiplicity of sources to plug the gap.

“Vaccinating 27 per cent through COVAX and another 20 per cent through others will not get us the 60 to 70 per cent population required to get herd immunity.

“This is the situation that we are facing now and this is one of the tasks that the president of ECOWAS and myself have been charged to set up.

“We will do something about that within the next fortnight and come back to our partners for their support,” he explained.

The Minister of Health, Dr. Osagie Ehanire, applauded the Deutsche Gesellschaft für Internationale Zusammenarbeit and the European Union for their generosity to the ECOWAS region “during this challenging time of the COVID-19 pandemic.”

“This is not the first time your organisation is showing generosity to the region and this gesture is worthy of commendation.

“WAHO has worked hard to tackle the considerable task of coordinating the entire process of bringing all parties together and ensuring timely delivery of medical supplies to member states,” Ehanire said.

NAN reports that the critical materials handed over included personal protective equipment, equipment for intensive care units such as oxygen compressors.

The equipment were the first of two consignments of more to follow that would be handed over to the ECOWAS Commission for distribution to the 15 member states.

(NAN)

More Nigerian Men Infected with COVID-19 than Women, Survey Reveals

6

… With over 40M Nigerians infected already

More Nigerian men infected with COVID-19 than women, Survey reveals
A Nigerian man undergoing COVID-19 test

Findings from a household seroprevalence surveys conducted in Lagos, Enugu, Nasarawa and Gombe States has shown that COVID-19 infection is more prevalent among Nigerian men than women, with over 40 million citizens infected already.

The survey, jointly conducted by officials of the Nigeria Centre for Disease Control (NCDC) and Nigeria Institute for Medical Research (NIMR) and their partners, done between September and October 2020 with the aim of improving estimate of the infection burden in the country, found that 1 in 5 Nigerians have been infected with the virus, which negates the official infection records daily display by the NCDC.

In a press statement announcing results of the survey, the researchers said: “Survey findings released today (Monday) revealed that the prevalence of SARS-CoV-2 antibodies was 23% in Lagos and Enugu States, 19% in Nasarawa State, and 9% in Gombe State. This means that as many as 1 in 5 individuals in Lagos, Enugu and Nasarawa State would have ever been infected with SARS-CoV-2. In Gombe, the proportion is about 1 in 10.

“Results of the survey further showed higher rates of infection among: 1) males than females (for example, 10% vs. 7% in Gombe and 21% vs. 17% in Nasarawa); 2) urban compared to rural and residents (for example, 28% vs. 18% in Enugu and 23% vs. 19% in Lagos); and persons aged 18-64 years. There were also variations across the local government areas (LGA) within the four states”.

While the latest infection update from the NCDC shows 154,476 confirmed cases, 131,699 treated and discharged with 1,891 deaths recorded in 36 states and the Federal Capital Territory, analysis of the survey implies that this is far from the reality of things in a country of 200 million. If 1 in 5 persons is infected, then simple arithmetic confirms it as 40 million. This is a validation to the fact that the country is really under testing due to limited facilities and resources.

In conducting the test, the team collected blood samples from over 10,000 individuals residing in a representative sample of households in the four states. The blood samples were then tested for the presence of SARS-CoV-2 antibodies applying locally validated laboratory tests. Individuals who provided blood samples also answered a brief questionnaire that enabled the study team to characterise factors related to positivity and identify which population groups were most affected.

The results from the survey show that a significant proportion of people in Nigeria are still at risk of SARS-CoV-2 infection and therefore, it is very important that Nigerians continue to adhere to public health and social measures including regular handwashing, proper use of face masks and physical distancing.

The statement further implied results from the survey, noting that “SARS-CoV-2 emerged only one year ago and antibody response according to severity of infection and the duration of antibody persistence are not yet completely understood. Given the high proportion of asymptomatic cases in Nigeria, the true seroprevalence of ever having infection may be underestimated in the survey if individuals infected early in the outbreak no longer had sufficient antibodies for detection when the survey was conducted”.

Meanwhile, the World Health Organisation (WHO) has disclosed that over 500,000 people, mostly from poor countries in Africa are in need oxygen 1.1 million cylinders of oxygen per day, with 25 countries currently reporting surges in demand.

Topmost on the list of the 25 low income countries with surge in oxygen supply are Malawi, Nigeria Afghanistan, among others.

The global health institution made the disclosure Friday via a press statement, as it launched a COVID-19 Oxygen Emergency Taskforce saddled with the responsibility of coordinating and advocating increased supply of oxygen, and, in partnership with the Access to COVID Tools Accelerator Therapeutics pillar (co-led by Unitaid and Wellcome).

Reacting to the shortage in oxygen supply in Africa, Dr Philippe Duneton, Executive Director of Unitaid, said: “This is a global emergency that needs a truly global response, both from international organisations and donors. Many of the countries seeing this demand struggled before the pandemic to meet their daily oxygen needs. Now it’s more vital than ever that we come together to build on the work that has already been done, with a firm commitment to helping the worst-affected countries as quickly as possible.”

“The taskforce has determined an immediate funding need of US$90 million to address key challenges in oxygen access and delivery in up to 20 countries, including Malawi, Nigeria and Afghanistan. This first set of countries has been identified based on assessments coordinated by WHO’s Health Emergencies Programme, in order to match in-country need with potential financing, such as through the World Bank and the Global Fund.

“Unitaid and Wellcome will make an immediate contribution of up to US$20 million in total for the emergency response. The urgent, short-term requirements of additional countries will be measured and costed in the coming weeks, with the overall funding need over the next 12 months estimated by ACT-A to be US$1.6 billion – a figure that will be regularly reviewed by the taskforce”, he quipped.

 

 

 

Pharmaceutical Marketing: Basic Concepts and Principles (2)

6

In the last edition, we touched on the fact that marketing is at the heart of any business success, as well as being an ever-present management function. A business basically is in existence because it has customers, and this further underscores the point that marketing is at the heart of business, as it involves the acquisition, maintenance and management of a firm’s relationship with customers.

Management gurus say that marketing is too important to be left for marketing. Great and successful companies have very often had CEOs who take on the role of Chief Marketing Officers.

Pharmaceutical Marketing: Basic Concepts and Principles (2)
Pharm. Tunde Oyeniran

 

Moreover, the marketing function is driven by some concepts and principles, irrespective of the product (services, places, ideas, persons, etc.) involved, and this includes pharmaceuticals. We have examined and explained the following concepts:

NEED: It is considered as a state of deprivation or lack, or an absence felt or observed by human beings.

WANT:  This is the exact form that our needs take in the process of fulfilling it, and is shaped by culture and individual personality.

DEMAND: This refers to want backed by buying power.

CUSTOMER VALUE AND SATISFACTION EXPECTATIONS: Value is considered to be the most exact measure of satisfaction.

EXCHANGE AND TRANSACTION: Exchange is the act of obtaining a desired item from someone by offering something in return, while transaction is trading between two parties that involves at least two things of value, agreed-upon conditions, a time of agreement, and a place of agreement.

MARKET: This comprises the actual and potential buyers of a product.

 

We will now proceed to look at other concepts, principles and issues that are necessary for understanding of marketing, branding and marketing management. Before we go on, lets illuminate the concept of market with the figure below:

 

 

Value chain and delivery network: Value chain is a series of departments, associated firms and service providers that carry out value-creating activities to design, produce, market, deliver, and support a firm’s products while value delivery network is made up of the company, suppliers, distributors, and, ultimately, customers who partner with one another to improve the performance of the entire system. Thus, while marketing influences its ecosystem, it is inexorably being influence in turn by its ecological system.

Product.  The product is anything that can be offered in a market for attention, acquisition, use, or consumption that might satisfy a need or want. It takes many forms. For instance, it may take the form of service (activities, benefits, or satisfaction offered for sale and are essentially intangible and don’t result in the ownership of anything), or experiences (what buying the product or service will do for the customer or what it makes the consumer feel). All in all, a product to a customer is seen as the complex bundles of benefits that satisfy their needs.

Price. Price covers the actual amount the end user is expected to pay for a product. More accurately, it is the cost the customer bears to enjoy the bundle of benefit offered by the product; that is, price offered, and the collateral costs of acquisition like, energy, opportunity cost, time used in the process of acquisition, etc. This is linked to what the perceived value of the product is to the customer, rather than an objective costing of the product on offer.

Place or placement has to do with where and how the product will be provided or made available to the customer. It is simply a matter of access and distribution is a key element of placement. How a product is accessed by the end user also needs to complement the rest of the product strategy.

Promotion. This is the communication and awareness creation for and about the product, price and placement and other things that the customer and potential customers need to know about the product. Promotion is just the communication aspect of the entire marketing function. This is about the best known of marketing activities and strategies. These may include advertising, sales promotions, special offers and public relations. Whatever the channel used, it is necessary for it to be suitable for the product, the price and the end user it is being marketed to.

Marketing mix. Marketing is sometimes defined as “putting the right product in the right place, at the right price, at the right time.” The use of a marketing mix is an excellent way to help ensure that “putting the right product in the right place,” will happen. The marketing mix is most commonly executed through the 4 Ps of marketing: Price, Product, Promotion, and Place. The relative and absolute “quantity” (read emphasis, amount of effort, level of importance) of each of the four Ps, depends on the product attributes, environment, price, target market, access strategy, cost, profitability, value, available resources, etc., and can be “mixed” in virtually infinitesimal ways and proportions. It is this idea that gave birth to “marketing mix”. Professionals see marketing mix as the specific/relative emphasis or proportion of the set of controllable tactical marketing tools—product, price, place, and promotion—that the firm “blends” to produce the response it wants in the target market.

Tunde Oyeniran, a Sales/Marketing Strategist, Selling/Sales Management Trainer and Personal Sales Coach is the Lead Consultant, Ekini White Tulip Consulting Limited, Lagos.  We deliver Training, Recruitment, Online Medical Communications Service and Field Force Management Solutions Feedback. Channels 080-2960-6103 (SMS/WhatsApp) /ekiniwhitetuliptraining@gmail.com or You can download our 2021 Program Schedule at https://fb.me/EkiniWhiteTulipConsulting

Local COVID-19 Vaccine not Feasible in Two Years – NNMDA DG

3

… Says FG needs reorientation on R&D

Local COVID-19 Vaccine not Feasible in Two Years - NNMDA DG
Pharm. Sam Etatuvie

In what would come as a disappointment to many Nigerians eagerly awaiting the production of an indigenous COVID-19 vaccine, following the approval of N10 billion by the Federal Government for same purpose, the Director General, Nigeria Natural Medicine Development Agency (NNMDA), Pharm. Sam Etatuvie, has said that the goal cannot be actualised in two years’ time.

According to him, despite the availability of human capacity, Nigeria has no structures in place to facilitate the production of a vaccine at the moment.

Etatuvie, who spoke with Pharmanews in an exclusive interview, also frowned at what he described as government’s discouraging attitude towards local inventions, saying such disposition would only keep the nation underdeveloped.

He cited the Pfizer and Moderna vaccines examples, noting that they were products of years of research ahead of the pandemic, an approach he said the Nigerian government needs to emulate.

Below is the full text of the interview:

 

COVID-19 has introduced a new normal order of running organisations across the globe. In what ways has your agency been affected?

Basically, we are a development agency. Our focus is on ethno-medicinal surveys, but due to restrictions in movement and issues of insecurity, our activities have been slowed down but we continue with our in-house product development.

One of our major jobs here is to train the practitioners to scale up product development and practice skills. We also train them on how to do documentation of their knowledge and raw materials. We normally go from zone to zone to conduct this training but the new normal prevented us and we did the training in-house last year.

We did two in-house trainings for herbs sellers. The essence was to encourage people to cultivate medicinal plants in order to have local raw materials readily available. Since medicinal plants have different species, there is need for a portal for identification of those species. At least, we were able to reach about 120 practitioners during our trainings last year.

 

As an institution for the development of natural medicines, how have you fared in developing local medicines for COVID-19?

As early as February last year, we produced our own natural sanitizer, which is 100 per cent natural. At a point, it was difficult getting the raw material for the sanitizer; so we looked inward to source local materials that have been proven to have certain bactericidal properties for the sanitizer and we got it done. We exhibited it at the Science and Technology Expo last year, and it received a lot of support from many participants. At this level, it is ready for commercialization. And we are reaching out to possible institutions or business owners who will be interested in marketing it effectively.

We were also able to research into a medicinal plant to develop our own local syrup called Kloviron.  We have done all the necessary tests that have confirmed that it has real potentials to prevent COVID-19. We even presented it to the committee that was set up by the Minister of Science and Technology and we provided all the information required by them. They also confirmed that it has potentials and promised to support the product but we are still waiting for their support.

 

What are the differences between your natural sanitizer and the imported ones?

The difference is clear, as we concentrated on using our indigenous medicinal plants. Most of the raw materials used for hand sanitizers are imported, such as Isopoponel, cadomal, pharmaceutical grade alcohol, etc. With the spike in dollar exchange rate, they became more expensive. So we resorted to using our indigenous alcohol that you can test to know its equivalent standard to the pharmaceutical grade alcohol and once that quality is derived, it is comparable to imported alcohol, and good for our use.

That way, we promote made-in-Nigeria products and the colour green is obtained from the aloe vera gel that we have in abundance here. It is 100 per cent local sanitizer. Instead of depending solely on imported materials, we can use our indigenous plants. This is a clear alternative to the imported ones.

In terms of pricing, at the laboratory level, it’s a bit higher in price, but when it gets to commercialisation level, it will be cheaper because there is no importation of materials involved. From the comparative analysis done, it shows that it competes favourably with others manufactured by pharmaceutical companies here.

 

Has any staff of the agency tested positive to COVID-19?

It is categorically no, because aside from government’s safety protocols, we encourage our staff to take our syrup as a prophylaxis, as it helps to build immunity. It has higher antioxidant properties. We have not taken it for commercialisation because we are still with NAFDAC for listing.

 

Is there any possibility of developing a vaccine from our indigenous medicinal plants?

I don’t think we have the capacity to produce a vaccine now; anybody can prove me wrong. We might have some human capacity but there is no structure for that in the country. It was just recently that the Federal Government mentioned that N10 billion will be released for vaccine purpose.

We have a vaccine facility in Yaba over these years; why hasn’t it been overhauled for this purpose? And since February 2020 when the index case came into Nigeria, why was not this N10 billion released since then? Now, this N10 billion will be first of all used in improving the facility on ground.  In the next one to two years, there can’t be a Nigerian-made vaccine.

It is a question of priority, as far as I’m concerned. I think we were more interested in building isolation centres at the initial stage than getting vaccines. We needed to have done those things pari passu. Besides, many of us that came up with products and seeking for assistance were not listened to.

These efforts from our agency haven’t got any support from government; we did them from our own pockets. Even when the Madagascar syrup came, we were one of the agencies that were given the syrup to analyse and after the whole exercise, nothing was given to us.

For me, there is absolute need for us in this country to change our orientation in things that concern Nigeria. It may interest you that this Moderna and Pfizer vaccines were work-in-progress for the past six year before the pandemic erupted. So when the outbreak occurred, they went back to their archives to see what they had at hand. That is how researches are done.

Even if institutions are deficient of facilities, how well have we identified local manufacturers in the country that may have the capacity to come up with something substantial? A lot of professors here have come up with formulas but nobody listens to them.

I know that one of our agencies, LASEMI, came up with the invention of a ventilator. After the announcement, nothing has been done to the equipment till date.  I recall that Innoson Motors’ CEO also mentioned a formula he had got but nothing is heard of it again. We didn’t even give them an opportunity to try their invention; we just have this attitude of not believing in ourselves, until someone comes from abroad to provide a solution for us.

Unless government changes its approach to research and development, we may not get anywhere.

 

Federal institutions like NIMR, NAFDAC and others have been collaborating with the NCDC in the fight against the spread of the virus, but your institution has been somewhat silent. Why is this so?

Yes, for NCDC, we haven’t collaborated with them, as we believe in letting our works speak for us. By the time these works are completed, we can collaborate more with the NCDC. Our own approach is different because we report directly to the Ministry of Science and Technology, as we are not existing in isolation. NIMR has been existing for a long while but it’s more of our approach.

We also did public enlightenment programmes for people on how to build their immune system. We did something on aroma therapy which is one of the indigenous ways of building up your immunity. If you also care, you would have heard that if you can inhale steam, it kills the virus. We did the first one which we circulated on TV and social media.

 

Ginger, garlic, garcinia kola and lemon tea has been recommended as preventive syrup for the coronavirus, but some have countered the effectiveness of the preparation. What is your take on this?

There is copious scientific information published in highly rated peer review journals that these plants have basic properties constituents that can take care of the infection. They have antiviral properties, anti-infective properties, anti-toxic properties, and are immune boosting. All of them have been proven to be effective.

Any true scientist in this sector cannot come and disprove that they are working. We know that these things are working but what is critical is to convince others that they are working. The first step is to finish all your formulation, do all your safety analysis, and meet all your NAFDAC requirement. Once NAFDAC gives you listing, it means at least people can use the procuct.

Let me ask you one question, with all these stay-at-home rules, what should people be doing? Self-isolate to do what? We don’t have formulations used in the isolation centres but they need prophylaxis to use. If we are sincere to ourselves, some enlightened people who had tested positive to the virus came out to say, “I used A…B…C.”

The only thing I can do if you come to me as a pharmacist is that I will give you an extemporaneous formulation but if we want to put it in public domain, then I will put it out for clinical trials, and that is not done in a day or two time; it takes time. Even the vaccine didn’t go through complete clinical trials and they were given emergency approval due to the pandemic and they say it is 95 per cent safe. There is no drug that is completely safe, even your paracetamol.

Research Shows Urine Test Could Detect Womb Cancer

3

Researchers from the University of Manchester have shown that a simple urine test could detect womb cancer which is also known as uterine or endometrial cancer, noting that the method could replace a painful and invasive procedure currently in use.

The findings, published on yahoo.com, says that the major symptom of the disease manifests as abnormal vaginal bleeding and this may prompt a medical practitioner to carry out a physical examination.

Research Shows Urine Test Could Detect Womb Cancer
Research Shows Urine Test Could Detect Womb Cancer

It also shows that women who are at risk could later be referred for an internal scan or biopsy, a process which requires a narrow telescope called a hysteroscope, to examine inside of the uterus and remove cells.

According to the research, nearly a third of women who undergo the procedure have the process repeated because of technical difficulties or intolerable pain they go through.

When tested on 103 women with diagnosed womb cancer and 113 with unexplained bleeding, the urine assessment detected the disease 91.7 per cent of the time.

“Our results show womb cancer cells can be detected in urine and vaginal samples using a microscope,” said lead author Professor Emma Crosbie.

“Women who test positive with this test could be referred for diagnostic investigations while women who test negative are safely reassured without the need for unpleasant, invasive, anxiety-provoking and expensive procedures.

“We think our new test could offer a simple, acceptable and easy to administer solution that could be used in primary care as a triage tool for women with suspected womb cancer, he added.”

Around 9,300 new cases of womb cancer arise every year in the UK. The survival rate is relatively good, with nearly three quarters (72 per cent) of patients living at least 10 years post-diagnosis in England and Wales.

In the US, more than 65,000 women are expected to have been diagnosed with womb cancer in 2012.

Under existing diagnostic guidelines, a woman with suspected womb cancer may have a transvaginal ultrasound scan (TVS), which involves placing a probe in the vagina to create a detailed image of the internal uterus. Some find the procedure uncomfortable, however, it should not be painful.

If the TVS detects changes to the womb lining’s thickness, the woman will usually be offered a hysteroscopy.

This is where a thin telescope is inserted into the womb via the vagina to better examine the uterus’ lining.

A sample of womb lining, a biopsy, is usually taken during the hysteroscopy.

Believing a new detection tool could be added to the existing regimen, the Manchester scientists tested their at-home urine collection method on more than 200 women, with and without diagnosed womb cancer.

Results, published in the journal Nature Communications, suggest the assessment identified the proportion of women with womb cancer 91.7 per cent of the time.

It also picked out women who did not have the disease in 88.9 per cent of cases.

“New strategies to facilitate early diagnosis of womb cancer are urgently needed to enable curative hysterectomy for women who present with biologically aggressive disease,” said Professor Crosbie.

“Though postmenopausal bleeding is a recognizable symptom, only 5 per cent to 10 per cent of women with it have sinister underlying pathology; so this test, if adopted, will put these patients’ minds at rest.”

Examining the samples under a microscope is reportedly already part of the NHS’ expertise.

Assessing urine samples would also be relatively inexpensive and quick, as well as potentially providing a woman with a diagnosis there and then.

The professor said while their data looks very promising, there is a need for them to confirm them in a larger diagnostic accuracy study of women with unexplained postmenstrual bleeding undergoing routine diagnostic investigations.

 

 

The World is Evolving, Pharmacy Education Cannot be Stagnant – PANS-OAU VP

24

In this exclusive interview with Pharmanews, Ganiyat Folashade Sanusi, vice president, Pharmaceutical Association of Nigeria Students (PANS), Obafemi Awolowo University, Ile-Ife, Osun State, lends her voice to the persistent call for a review of pharmacy education in the country. The 400-Level students’ leader also speaks on her foray into Pharmacy, the effects of the COVID-19 pandemic on their administration, and other issues. Excerpts:

Tell us about your experience as a pharmacy student in the last four years and what prompted your decision to study Pharmacy?

For me pharmacy school has been an emotional rollercoaster. I decided to study Pharmacy because of the diverse nature of the profession, and it gives chance to explore some other skills. Those are some of the reasons I opted for it.

The world is evolving, pharmacy education cannot be stagnant – PANS-OAU VP
Ganiyat Folashade Sanusi

 

What aspects of your responsibilities as the vice president, PANS-OAU, do you consider particularly challenging, and how have you been coping?

The role of the vice president is not new to me as I had served as vice president and president of some associations on campus, including the Drug Free Club and others. From experience, I would say the fundraising aspect, which is one of the major roles of the vice president, has to be the most challenging. Due to the pandemic and economic downswing, it has been a little more intense than usual, but we are still trying to make the best out of the situation.

 

The year 2020 was riddled with lots of challenges, ranging from COVID-19 pandemic and civil unrest nationwide, how many of your administrative goals for the year were achieved?

Very few of our goals have been achieved yet. The pandemic set in just two weeks after the school resumption, just when we were about to have our freshers’ week. The only thing we were able to execute before the pandemic was tutorials for the new students on campus and those in the faculty.

Also, during the pandemic, quite a number of webinars were   organised to keep pharmacy students engaged, regardless of the situation.

 

There have been various complaints concerning the pharmacy curriculum. What are your thoughts on this?

I would just like to say that the curriculum can be way better than it is now, if most of the irrelevancies are scrapped. The world is evolving, let’s be updated too – not just doing the same thing the way it’s been done years before some of us were born.

 

How would you react to the emergence of Pharm. Yimika Oguns as the new PSN-YPG national chairman? And what are your suggestions to the group?

I have worked personally with Pharm. Yimika Oguns before and I am most certain she is the best candidate for the position. She is going to deliver the best of her abilities, as her previous records can prove that she is a very good team leader.

I would suggest that they keep all the promises made in their manifesto and set a good pace for us incoming young pharmacists.

How did you see last year’s PSN conference in Osogbo, Osun State?

I must admit that I was amazed that the conference could be so well-organised and well-attended, despite the pandemic and the economic downswing.

What is your view on student unionism?

Violence most times yields no result but causes more damage. I would choose protest over violence to air my views about a situation that isn’t well attended to.

JIK Gets Endorsement by the National Association of Nigeria Nurses & Midwives to Promote Good Hygiene Practices in Nigeria

2

Online Press Release

Nigeria’s leading hygiene and household disinfectant brand, JIK has announced a strategic endorsement with the National Association of Nigeria Nurses and Midwives (NANNM) to promote hygiene practices in Nigeria.

JIK Gets Endorsement by the National Association of Nigeria Nurses and Midwives to Promote Good Hygiene Practices in Nigeria
L-R: General Secretary, National Association of Nigeria Nurses and Midwives (NANNM), Comrade Thomas Shettima and Senior Brand Manager, Hygiene, Reckitt Benckiser (RB), West Africa, Cassandra Uzo-Ogbugh during the signing of a Memorandum of Understanding (MOU) Endorsing JIK as an effective hygiene and household disinfectant brand in Abuja.

This partnership is in line with JIK’s long-term vision to realise a world where families are safe from illness-causing germs & viruses.

NANNM is a professional-cum trade union organization of all professional nurses and midwives who are trained, registered, and licensed to practice the nursing profession at all the levels of the healthcare delivery system.

According to the brand, the strategic endorsement deal will enable Reckitt Benckiser (RB Nigeria), through its brand JIK, to further encourage good hygiene practices in communities and the public through several far-reaching bouquet of programmes. It will also help to create and release public awareness messages, campaigns, and sponsorship on public health and personal hygiene to promote and increase awareness of health and hygiene matters among the public.

JIK Gets Endorsement by the National Association of Nigeria Nurses and Midwives to Promote Good Hygiene Practices in Nigeria
L-R: General Secretary, National Association of Nigeria Nurses and Midwives (NANNM), Comrade Thomas Shettima; Senior Brand Manager, Hygiene, Reckitt Benckiser (RB), West Africa, Cassandra Uzo-Ogbugh and Regional Manager, Reckitt Benckiser (North), Victor Okafor during the signing of a Memorandum of Understanding (MOU) Endorsing JIK as an effective hygiene and household disinfectant brand in Abuja.

Speaking on the Endorsement, Country Manager, RB Hygiene West Africa, Asif Hashimi stated “Our Endorsement by the NANNM is a perfect fit since we both share a common objective to promote good hygiene practices. Nurses are most times the first point of call when individuals get ill, with this endorsement, we can collaborate to drive high standards in hygiene practices. With JIK, our Fight is to empower individuals to keep their families safe from illness-causing germs & viruses’’.

He went on to add, “It is a critical time globally, and this partnership with the NANNM will help to further amplify our message of good hygiene practices. Over the years, Nigerians have come to trust JIK to keep their homes in a good sanitary state and help curb the spread of infectious diseases in their families, this endorsement by NANNM will further help to entrench trust. JIK is safe for the environment as it kills 99.9% of illness-causing germs on surfaces, laundry, and in the environment.”

 

JIK Gets Endorsement by the National Association of Nigeria Nurses and Midwives to Promote Good Hygiene Practices in Nigeria
L-R: Regional Manager, Reckitt Benckiser (North), Victor Okafor; Senior Brand Manager, Hygiene, Reckitt Benckiser (RB), West Africa, Cassandra Uzo-Ogbugh; General Secretary, National Association of Nigeria Nurses and Midwives (NANNM), Comrade Thomas Shettima and Deputy General Secretary, NANNM, Barrister Samson Eze Ikenna during the signing of a Memorandum of Understanding (MOU) Endorsing JIK as an effective hygiene and household disinfectant brand in Abuja.

In his remarks, General Secretary of NANNM, Comrade Thomas Shettima, said the association was proud to identify with JIK. “Reckitt Benckiser’s products are well-tested and the efficacy of their products – especially JIK, is not in doubt; the reason for our endorsement. We are confident that this will further promote the acceptance of the brand.”

With the Memorandum of Understanding signing, the association has granted RB the exclusive right to use its official logo on all its JIK products and brand materials. Every RB’s advertising material for JIK products and brands on all media platforms will likewise carry the association’s official endorsement and logo.

JIK is a product of Reckitt Benckiser, makers of world-renowned household brands such as Dettol, Mortein, Harpic, Airwick, Durex, Nurofen, Gaviscon, and many more. The brand continues to play an important role in the sensitization of citizens on the dangers of germs on surfaces and the importance of healthy hygiene practices in Nigeria.

End

Medical Practice in Nigeria Still Technologially Backward – Efunnuga

2

Dr Kunle Efunnuga is a Ukraine-trained surgeon who returned to Nigeria in 2001 to set up Hope Home Hospital. He graduated from the National Medical Institute of Ukraine and obtained a PhD in Surgery from the Ukrainian Institute of Postgraduate Studies in Kharkov. In this exclusive interview with Pharmanews, he outlines factors that can transform  the Nigerian healthcare delivery system. Passionate about the welfare of the average Nigerian citizen, Efunnuga  believes that the provision of job opportunities and basic necessities can help put an end to the many societal aberrations bedeviling the country, including those in the medical profession. Excerpts:

How would you compare medical practice in Europe with that of Nigeria? What do you think we are doing better or otherwise?

First, you cannot compare the two because we are here in the tropics and our kind of Medicine is different from their own. The bulk of our Medicine is different from theirs. What I can categorically tell you is that we are a bit backward in terms of technology because we have not really invested in it.

Surgeons over there are far ahead of those here because while they have been talking about robotic surgery, we are still tearing and cutting here. You just can’t compare. They are two different worlds apart.

Dr Kunle Efunnuga

The second wave of the coronavirus pandemic seems to be taking more lives than the first, yet, many people still believe it is a scam used by the government to garner foreign monetary aid. What advice do you have for such people?

The problem is everywhere. It is not peculiar to Nigeria. In the United Kingdom, there are people who are against the use of face masks. They believe that the social restrictions brought about by COVID-19 are forms of enslavement; and so, they want to be free by protesting against the safety protocols.

Government is trying to force people to comply. It is a universal problem. Another factor is that those who have not experienced the virus may not actually believe it exists. It is unlike people who have experienced it directly or indirectly.

Above all, I would say that people’s refusal to accept that the coronavirus is real should be seen as a world problem that is not peculiar to any particular nation. My children who school in Ukraine tell me that you cannot visit any public place without a face mask. At all entry points, you will find people who sell them and you must comply or risk arrest.

The only advice I have for those who are still doubting the existence of the virus is that, it has come to stay and it is very real. Even though our government may not be trusted when it comes to managing money, I believe we should have it in our minds that COVID-19 is real.

The Federal Government says it has invested so much in the country’s primary healthcare system but you still find people dying of common ailments like malaria. What really is the problem?

You cannot claim to have invested so much in the primary health care when there are no drugs available, even in the teaching hospitals. You remember that there was a time the First Lady was complaining about the sorry state of Aso Rock clinic, in spite of the billions of naira that successive government have spent on it.

Our people are corrupt. They see every opportunity as a window to embezzle money.  They don’t care what happens to other people; all they want is to steal and acquire illicit wealth. Until our mentality changes and until we begin to see ourselves as brothers and sisters, things will not change.

The prevalence of quacks and fake drugs seems higher in low-brow areas. People who are not even qualified as patent medicine dealers perform abortions and surgeries. What is the NMA doing about this?

The NMA cannot be running after such people because they have other pressing issues to talk about. The government and the pharmaceutical regulatory agencies should be proactive.

In a normal country, you can’t just go to the counter and buy a drug. Again, factors like unemployment have made things worse here. People will always find a way to survive, no matter how you try to stop them. Trying to stop them is like chasing the wind and trying to catch it. You can’t catch the wind. Government must provide jobs for the people to keep them out of such unwholesome practices.

If you were consultant to the Federal Government on health,  what advice would you give for the betterment of the Nigerian health sector?

The sector is very defective. The Bible says, “If the foundation be destroyed, what can the righteous do?” When many aspects of our national life is faulty, others will automatically be affected.

What is working in Nigeria? Is it electricity? Is it security? See the way Fulani herdsmen are killing people and the government is not saying anything about it. The president is not talking and culprits are not being arrested.

So many things have to be changed in this country without looking at anybody’s face. Most importantly, when job opportunities are created, people will think less of going into illegal ventures. Before anything can work in Nigeria, good laws that would favour all agencies must be made. We need to sit down and re-organise the country.

Ketamine anesthesia is associated with:

29

Ketamine anesthesia is associated with:

a) Cardiovascular stimulation

b) Increased cerebral blood flow, oxygen consumption and intracranial pressure

c) Disorientation, sensory and perceptual illusions, and vivid dreams following anesthesia

d) All of the above

Nigeria can’t Produce COVID-19 Vaccine without Passage of PCN Bill, Says PSN

2

– Give reasons for delay in vaccine arrival

Nigeria can’t Produce COVID-19 Vaccine without Passage of PCN Bill, Says PSN
Pharm. Gbenga Falabi, national secretary, PSN and Pharm.(Mrs) Ijeoma Okey-Ewurum, national publicity secretary, at the media briefing.

The Pharmaceutical Society of Nigeria,PSN, has insisted that until the Pharmacists Council of Nigeria, PCN Bill is passed at the National Assembly, there is no possibility of producing a COVID-19 vaccine in the country.

The PCN Bill is the law regulating medicines production in the country and everyone involved in Pharmacy practice, including those in the open drug markets.

Addressing journalists on the roll out of COVID-19 vaccines in Nigeria on Wednesday, the PSN President, Pharm. (Mazi) Sam Ohuabunwa, stressed that without the PCN Bill being passed into law by the National Assembly, the World Health Organisation, WHO would not grant Nigeria the approval for vaccine production.

“PCN Bill and vaccine production are like a twin which cannot exist without the other. Situations have arisen in the past when NAFDAC approached the WHO for approval on similar issue, but when the former PCN Bill was presented as a requirement, it was turned down on the basis of weakness. Hence, the need for the passage of the new bill arises.

“We have the science and technological know-how, in fact if the Bill is passed into law today, I can tell you that in less than 18 months, we can give the government a detailed proposal for the production of COVID-19 vaccine”, Ohuabunwa asserted.

The PSN President, who was ably represented at the briefing by the National Publicity Secretary, Pharm.(Mrs) Ijeoma Okey-Ewurum hinged Ghana’s reception of COVAX COVID-19 shots ahead of Nigeria with a larger population and infections on inadequate provision of facilities to maintain the cold chain protocols as well as meagre investment in the healthcare sector.

He however noted the importance of collaboration of healthcare workers in vaccination, saying all stakeholders must be well intimated and integrated into the vaccination exercise. “The place of pharmacists, the custodians of drug and drug information, is fundamental”, he maintained.

Explaining further on the bill, the number pharmacist in the country said it is impossible to enforce a law that is not in existence.

He likened the scenario to a case where an individual produces a vaccine at his backyard and thereafter the jab kills five persons and when sued to court, he was charged N50,000 or three months imprisonment. That does not make sense to the WHO, thus described it as a weak bill. And the need for the approval of the reviewed bill.

PCN Registrar, Pharm. N.A.E. Mohammed, sometimes last year had highlighted the merits of the new Pharmacy Bill over the previous one.

He stated that it will help arrest the current trend in which drugs are made available through illegal and unregistered outlets. It is all encompassing and addresses the gaps inherent in the extant Act and will help guarantee public health, since it provides adequate sanctions in the event of a breach of any of its provisions.

The offenses covered by the new law, he explained, are unprofessional conduct; failure to register premises; refusal to dispense drugs and poisons; control of sale of patent and proprietary medicines; provision or supply of dangerous and restricted drugs; improved access to quality, effective and affordable medicines through introduction of satellite pharmacy and introduction of the concept of chain pharmacy.

Other members of the Pharmacy National Executive Council present at the meeting were: the National Secretary, Pharm. Gbenga Falabi; Editor and Dr Lolu Ojo.

Vitamins are:

8

Vitamins are:

a) Inorganic nutrients needed in small quantities in the body

b) Organic substances needed in very large quantities in the body

c) Any of various fat-soluble or water-soluble organic substances essential in minute amounts for normal growth and activity of the body and obtained naturally from plant and animal foods

d) Products of endocrine gland secretion

Getz Pharma to Revolutionise Respiratory Diseases Treatment – Business Manager

1

– Donates educational audio-visual unit to LUTH

Getz Pharma Nigeria Limited has disclosed its readiness to revolutionise treatment of asthma and other respiratory diseases, by enhancing patient education though partnership with stakeholders.

Speaking with Pharmanews in a recent interview, the Country Manager, Getz Pharma, Mr Shujaat Ali Khan, said the company has started implementing the objective by setting up Asthma Club, an initiative to enhance asthma knowledge, practice and control among patients and Nigerians at large.

Accordingly, the company, on 3 February, 202, presented a wall-mounted educational audio-visual unit to the Respiratory Unit of the Lagos State University Teaching Hospital (LUTH).

In his remarks shortly after the presentation, Khan noted that Getz Pharma is a socially responsible company that is very much interested in executing projects that will positively affect the Nigerian society.

He also highlighted that Getz Pharma is one of the fastest growing pharma companies in Nigeria because of the quality of its products, manufactured in its World Health Organisation pre-qualified facility.

He said: “We are interested in how to help the society. We are not just interested in our frontline customers like doctors and pharmacists but also the society at large, by embarking on some projects that will have positive impacts on the society.

“As a socially responsible company, we have a lot of plans. We are also launching other plans, which include general symposia for antimalarials. We have a plan to go to schools to educate the children. There are several plans in the pipeline; although COVID-19 has really affected many things, we are hopeful that by middle of this year, things will get better. We have good plans for patients’ education, as well as society education.”

Also speaking at the event, the Business Manager of Getz, Dr Funsho Oloruntoba, explained that the presentation of the audio-visual unit is a sign of better things to come in the pharmaceutical and healthcare industry in Nigeria.

“We are going to revolutionise respiratory products and treatment in Nigeria and this will impact every patient in the country that will need our products at every point in time. We have got good reactions as far as respiratory illness is concerned in Nigeria.

“The same thing that we have done today will be extended to other parts of the country. Getz Pharma is ready to collaborate as much as possible with teaching hospitals that we can reach out to,” Oloruntoba said.

Reacting to the gesture by Getz, the Head, Department of Medicine, LUTH, Professor Njideka Ogunbadejo, commended the company, saying that the donated device will go a long way in the treatment of asthma and other respiratory diseases in the Hospital.

L-R: Kehinde Bankole,product manager, Getz Pharma; Professor Njideka Okubadejo,HOD Internal Medicine department, LUTH; Dr Michelle Dania, consultant pulmonogist; Mr Shujaat Ali Khan, country head, Getz Pharma; Dr Obianuju Ozor, consultant pulmonologist & head of respiratory unit, LUTH; Dr Funsho Oloruntoba, business manager, Getz Pharma; Back left to right: Omolade Bolaji, territory manager, Getz pharma; Harrison Opone, area sales manager; Abigail Ojo, ass. product manager,Getz pharma; Chinedu Anokwulu, product manager,Getz Pharma; Dr Ogundare Adewale, senior registrar, int. medicine LUTH; Dr Ekete Ogoo, senior registrar, int. medicine LUTH; Dr Tekobo Abiodun, senior registrar, internal medicine LUTH.

“I am grateful to Getz Pharma for their kind gesture towards the Respiratory Unit. Patients’ education is very important. It is more important for asthmatic patients to understand the disease and the role they need to play in managing it.

“Having an asthma club that is being facilitated by Getz Pharma is a huge one for us because it will enable a more relaxed interaction between the patients and the pulmonologists that give them care. The patients will be able to learn about the disease in the best language they understand. I am really proud to be associated with Getz Pharma,” Ogunbadejo said.

The Head of Respiratory Unit, LUTH, Dr Obianuju Ozor, in her remarks commended Getz for the donation, while soliciting greater partnership with the organisation.

She said: “On behalf of the Respiratory Unit, I want to express appreciation to Getz Pharma for the presentation. The wall screen audio-visual unit will go a long way in improving the care we render to our patients. Lack of asthma education is an important reason many patients don’t have control over their asthmatic condition but the device that Getz Pharma has presented, where patients will learn and get educated will improve the care we render to our patients.

“Getz Pharma has been supporting the Respiratory Unit with their products and quality, affordable medications. We are happy to partner with them and we are looking forward to a greater partnership in the years ahead.”

Similarly, the pulmonologist in the unit, Dr Michelle Dania, showered encomium on Getz, saying the device presented by the company will enhance the wellbeing of asthma patients in the hospital.

“Patients’ education is an important part of asthma management. You need to partner with asthma patients and counsel them on how to take their medications properly, or else, they will not get better. But having something that will give them audio-visual aid is a fantastic one that will go a long way in their wellbeing.

“So we really commend Getz Pharma for this kind gesture. We can’t wait to get the Asthma Club start running on the audio-visual unit that Getz Pharma has presented to us”, Dania said.

Olamide Brown  – West-Africa’s Trailblazer in Emergency Medical Care

2

It is a well known fact that adequate EMS is associated with improved outcomes in road traffic injuries (RTI), work-related accidents and for patients who need critical health attention.  However, for many years, Nigeria has struggled with poor healthcare infrastructure and inadequate emergency medical services, (EMS). This has led to countless unavoidable deaths, especially for people in high-risk areas.

Olamide Brown

It was this abysmal reality that  spurred a British-Nigerian doctor, Olamide Brown, to establish the West-Africa’s first Air Ambulance Service to bring trauma care to thousands people in Western Africa with her company – Flying Doctors Healthcare Investment Company, founded in 2011. Today, her company has the largest network of ground and air ambulances (both fixed and rotary wing aircraft) in West Africa.

Flying Doctors Healthcare Investment Company operates and invests in healthcare/wellness projects in Africa across the value chain from drug manufacturing, medical logistics, and retail pharmacies, to biotechnology and Telemedicine. Currently, the company’s investment portfolio is valued to be over $200million and growing rapidly. The award-winning company has been featured on various local TV and radio stations, as well as the BBC and CNN.

At the height of the corona virus pandemic, Brown and her FDHIC team launched a COVID-19 mobile testing booth, which reduces the need for as much PPE and minimises the risk of healthcare worker infections by providing a barrier between the potentially infected patients.

 

Background and education

Dr Olamide Orekunrin-Brown was born in 1986 at a seaside town called Lowestoft in the east of rural England. She hails from Ilawe-Ekiti in Ekiti State of Nigeria but grew up under the care of foster parents in the UK.

Brown acknowledges the immeasurable contribution of her late foster mother, Doreen Clarice Chalkley, describing her as a great woman who lived an exemplary life and left a wonderful legacy for her loving family and friends.

At the age of 15, Brown completed her secondary education and passed her A-Levels with flying colours. She gained admission for her medical degree at the University of York Medical School where she trained and graduated as one of the youngest medical doctors at age 21 in 2007. She supported herself all through school by working part-time.

In 2008, she worked in Acute Medicine NHS in the West Midlands, United Kingdom and then went on to be awarded the Japanese MEXT scholarship in 2009 which allowed her to further her studies in Tokyo, Japan. The fellowship focused on lab-based research with induced pluripotent stem cells. During her study in Japan, she worked within 23 wards in Jekei University Hospital and completed her fellowship in December, 2010.

She is currently completing her study for a master’s degree in finance and economic policy at the University of London and also has a certificate in Economic Policymaking from IE business school, Spain and a certificate in accounting for decision-making from the University of Michigan in the United States.

 

Venture into emergency medical service

From her days in medical school, Brown had always been interested in creating new means of healthcare delivery, devising the fastest ways of getting patients to the best healthcare facilities for their ailments.

Her personal experience also motivated her to venture into emergency medical service when her younger sister tragically died whilst on holiday with relatives in Nigeria. The local hospital was unable to manage her sickle cell anaemia condition, and as a result, Brown and her family started to search for an air ambulance so that her sister could be safely transported to a suitable medical facility in the country.

Unfortunately, there were no air ambulances to be found in Nigeria. The search also took them to Ghana, Sierra Leone and Cameroon, and across West Africa.  The only available one was in South Africa, and by the time the logistics had been arranged, her sister had passed on.

Determined to improve on the level of healthcare infrastructure in the country, Brown set up Flying Doctors Nigeria. The company has so far airlifted hundreds of patients, using a fleet of planes and helicopters to rapidly move injured workers and critically ill people from remote areas to hospitals. Ranging from patients with road traffic trauma, to bomb blast injuries, to gunshot wounds, Brown and her team are helping to save lives by moving these patients quickly and safely, while providing a high level of medical care en route.

Brown also runs an early stage venture capital firm, Greentree Investment Company, along with two other directors. The company provides growth capital to some of Africa’s most exciting tech start-ups. Greentree has invested in start-ups in various sectors including Fintech, media, SaaS, agric-technology, manufacturing, ecommerce, health-tech and Edu-tech making it one of West Africa’s leading venture capital firms. The total value of the Greentree portfolio is over $80m.

Brown  is also a talented author; her publications have been featured on various media platforms. She is an editor of the International Journal of Emergency Services. She has also written articles in the British Medical Journal, the Journal of Emergency Medical Services, the Niger Delta Medical Journal, the New York Times and the Huffington Post.

 

Awards and recognitions

Brown is a recipient of many awards and recognitions, among which are Mouldbreaker’s Award, THIS Day Award 2012, The Future Award as Entrepreneur of the Year, New Generation Leader for Africa, Ladybrille Personality of the Month, Silverbird Entrepreneurship Award (2018), the Most Influential Person of African Descent (MIPAD) recognition, Nigerian Aviation Personality of the Year Award and Vanguard WOW Awards.

She is also a TED Global Fellow (2012), a Dangote Fellow, an Aspen Institute New Voices Fellow (2013). She was among Forbes Africa’s 30 Under 30 for 2015, and has been honoured by the World Economic Forum as a Young Global Leader.

COVID-19 has Revealed True Value of Pharma Industry – MD, May & Baker

0

A consummate pharmacist who had worked with some of the biggest names in the global pharmaceutical firmament before mounting the saddle of leadership as CEO of May & Baker, Pharm. Patrick Ajah dissipates an air of enthusiasm in his approach to duty. He is very passionate about innovation and growth. In this exclusive interview with Pharmanews, the University of Ibadan graduate of Pharmacy reveals how he is building on the solid foundations laid by his predecessors. He also calls on the Nigerian government to partner with the private sector in creating an enabling environment for research and development in the pharmaceutical industry. Excerpts:

Sir, what would you say is the most important factor that has kept May & Baker going all these years?

Just In: Ghana gets First COVAX Vaccine Doses Delivered 

1

 

 

Just In: Ghana gets First COVAX Vaccine Doses Delivered 
First shipment of COVAX shots recieved in Ghana

The long awaited COVAX COVID-19 vaccine doses  have just been delivered in Accra, Ghana on Wednesday, making the West African country first recipient of the shipment.

Announcing the arrival of the vaccine in Ghana,  the World Health Organisation, WHO and United Nations children’s agency, UNICEF, in a jointly  signed statement said “A flight carrying 600,000 doses of the AstraZeneca/Oxford vaccine produced by the Serum Institute of India landed in Ghana’s capital Accra”.

The delivery comes almost a year after the WHO first described the novel coronavirus as a global pandemic and eight months after the launch of the COVAX initiative, aimed at pooling funds from wealthier countries and non-profits to develop a COVID-19 vaccine and distribute it equitably around the world.

The shots will be used to kick-start a vaccination drive that will prioritise frontline health workers and others at high-risk, according to a plan presented by Ghanaian health officials on Friday.

“This is a momentous occasion, as the arrival of the COVID-19 vaccines into Ghana is critical in bringing the pandemic to an end,” Anne-Claire Dufay of UNICEF Ghana, and WHO country representative, Francis Kasolo, said in the statement.

“These 600,000 COVAX vaccines are part of an initial tranche of deliveries … which represent part of the first wave of COVID vaccines headed to several low and middle-income countries,” they said.

The roll-out in Ghana is a milestone for the initiative that is trying to narrow a politically sensitive gap between the millions of people being vaccinated in wealthier countries and the comparatively few who have received shots in less-developed parts of the world.

It aims to deliver a total of 2.3 billion doses by year-end, including 1.8 billion to poorer countries at no cost to their governments, and to cover up to 20% of countries’ populations. But it will not be sufficient for nations to reach herd immunity and effectively contain the spread of the virus.

The African Union (AU) has been trying to help its 55 member states buy more doses in a push to immunize 60% of the continent’s 1.3 billion people over three years. Last week, its vaccine team said 270 million doses of AstraZeneca, Pfizer and Johnson & Johnson vaccines secured for delivery this year had been taken up.

China has donated small batches of its Sinopharm vaccine to countries including Zimbabwe and Equatorial Guinea. And Russia has offered to supply 300 million doses of its Sputnik V vaccine to the AU scheme along with a financing package.

But many countries are largely reliant on COVAX.

On Tuesday, WHO Director-General Tedros Adhanom Ghebreyesus urged wealthy nations to share vaccine doses with COVAX, saying the goal of equitable distribution was “in jeopardy.”

“So far 210 million doses of vaccine have been administered globally but half of those are in just two countries,” Tedros said in Geneva. “More than 200 countries are yet to administer a single dose.”

COVAX is co-led by the WHO, the GAVI vaccines alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and the United Nations children’s fund UNICEF.

It was launched in June 2020 to try to prevent poorer countries being pushed to the back of the queue for COVID-19 vaccines as wealthier nations bought up billions of doses for their populations.

COVAX said this month that it had allocated the first tranche of 330 million doses of vaccines for 145 countries, including several in West Africa.

Reuters

 

 

 

Enjoy Amazing Health Benefits of Zobo Drink

2

Zobo drink, known in many Nigerian homes is a very healthy drink, with several useful properties. Studies have found that it is not only capable of curing diseases but also effectively fights against excess weight.

The name is derived from the name of the parent plant called Zoborodo (in the Hausa language), Ghanaians refer to it as Zobolo, while Hibiscus sabdariffa is the scientific name of zobo.

Hibiscus sabdariffa is a species of Hibiscus probably native to West and East Africa and South-East Asia including Northeastern India.

The main essence of this plant are the leaves as mixing it with different grades, drink turns tasty, colourful, and pleasant. People believe that the Hibiscus has its own certain force.

A food coach in New York City and a M.S., certified dietician nutritionist, Dana James said while solids are obviously a major source of calories and fat, the liquids you take in can also affect the scale in a big way.  She added that it’s so sneaky because it’s such a subtle effect and that is why people don’t evaluate what they drink in the same way, so they don’t realize how much they’re consuming.

“If you want to lose weight, you have to watch what you drink. So, if you want to reduce your body weight, you need to consume drinks that are calorie-free and that will boost your body metabolism”, she added.

According to scientific findings, the effectiveness of zobo drink for weight loss shows that fat metabolism was found to increase on the administration of Hibiscus extracts resulting in weight reduction.

How does this work?

Appetite regulator: Zobo drink helps in managing appetite effectively: An anonymous said whenever I take zobo drink in the morning, I find it hard to take any other food because I get so full. With this, you have just little appetite for food and this will make you eat less and lose some weight.

Powerful ingredients: Zobo drink contains some ingredients that are very nutritious for the health. The ginger, usually added to it is a powerful medicinal herb on its own and all the fruits (pineapple, orange, water, and watermelon) added are storehouses of powerful antioxidants, phytochemicals and vital nutrients needed for the optimum functioning of the human body.

Promotes diuresis: Zobo drink also acts as any substance that promotes diuresis, the increased production of urine. This gets rid of your body’s excess water and avoids excessive bloating. Hence, zobo drink can be used to maintain a flat tummy.

Immune booster: Zobo drink contains many substances that may protect your cells against free radicals, which may play a role in heart disease, cancer and other diseases. It also increases a person’s body metabolism and overall health. These antioxidants also help protect the body from free radicals, thus strengthening the immune system of the body.

Aids speedy recovery: Zobo and its compounds have been linked to many health benefits, including aiding digestion, boosting immunity and speeding up recovery from surgery, among others.

Nutritional components of Zobo

A study conducted by the American food engineering journal, published in scialert.net found that dark zobo drink contains Vitamin C (7.5 mg g-1), calcium (4 ppm) and ash (15.5 per cent) content, the bright red recorded a high value in only magnesium (13.25 ppm) and the wine however, recorded the highest value in sodium (50.67 ppm), potassium (235 ppm), iron (1.17 ppm) as its highest percentage component.

This simply means there is also magnesium, sodium, potassium and iron in  zobo. Zobo’s drink pH is also pretty high. Which means zobo is actually very acidic with pH ranging from 2.5 to 2.7 regardless of the colour of the beverage.

Zobo can be seen to contain a high proportion of minerals and vitamin C. The nutrients it contains, such as magnesium and sodium, help to build strong bones in children.

How to make rich zobo

You will need:

  • A large pot
  • 3 cups of zobo leaves depending on how you want the quantity
  • 8 cups of clean water
  • 2 glasses of orange juice and dried peel of orange
  • 1 glass of lemon juice and dried peel
  • 2 tablespoons of konafuru
  • 1 tablespoon of dried chili pepper (preferably)
  • 1 tablespoon of powder of ground cinnamon
  • 2 tablespoons of organic honey to add to taste
  • 3 fresh gingers or two teaspoon of grinded ginger
  • You can as well add watermelon, cucumbers, pine apple, apples and other fruits of your choice.

How to prepare

  • Fill two cups with leaves of zobo, put them in a colander (kitchen utensil used to strain foods such as pasta or to rinse vegetables) and properly rinse with cold water.
  • It is desirable to use a strong pressure of water. Take a carnation and grind into powder. Prepare other components. Clean citruses of a dried peel. As for ginger, clear skin and make a puree of it.
  • Mix leaves of zobo and 6 cups of cold water in a pot. Put on fire. In addition, there are people who prefer to cook zobo leaves separately like tea and then to mix them with other ingredients.
  • Taste of drink is more intensive when you allow leaves to mix up slowly with other components. The result is a very rich and dense juice. The strong heat also destroys aroma, as well as low temperature.
  • It will take time, but results are worth it. When mixture begins to boil, take it from the fire. Also, add a few dry flakes of chili. One drink and you can try all fragrant spices getting through your flavoring receptors.
  • When the mixture has been well-cooked, you bring it down from the fire, sieve it and re-boil them. After it has boiled again, sieve it and you can now throw them away.
  • Allow the sieve to cool. When it has cooled, add the pineapple and orange juices to the zobo drink. You also add the diced fruits and stir well with a wooden stick or long spoon.

Congrats! Your rich zobo drink is ready to enjoy

  • You can pour the drink into containers and store them in the fridge and take it regularly.
  • You can take this drink without adding sugar, artificial sweeteners, and colourings. The pineapple and orange juices and the fruits added will sweeten it naturally.

 

 

 

All of the following statements regarding diuretics are true, EXCEPT:

27

a) Carbonic anhydrase inhibition leads to increased reabsorption of NaHCO

b) Loop diuretics decrease Na+ reabsorption at the loop of Henle by competing for the Cl-
site on the Na+ /K+ /2Clcotransporter

c) In general, the potency of a diuretic is determined by where it acts in the renal tubule

d) Hydrochlorothiazide decreases urinary calcium excretion

COVID-19: New Heights Donates Medical Equipment, Palliatives to Onigbongbo Community

2

To ameliorate the effects of the raging COVID-19 pandemic on its host community, New Heights Pharmaceutical Limited, a Lagos-based pharmaceutical company, has donated medicines, medical equipment and other palliatives to Onigbongbo community in Maryland, Lagos.

The donation was made to the Onigbongbo Primary Health Centre by the Executive Director of the company, Pharm. Olubunmi Omaruaye, at an event attended by the Oba of Onigbongbo, His Royal Highness (HRH) Olusegun Adeyemi, some members of his cabinet, officials of Onigbogbo Local Government and other prominent members of the community.

L-R: Hon. Monsuru Bolaji, the represesntative of the Onigbongbo Local Govt Chairman; His Royal Highness, Oba Olusegun Adeyemi Ajasa Olashide; Pharm (Mrs) Olubunmi Omaruaye, executive director of New Heights Pharmaceuticals; and Dr (Mrs) Folashade Tawak, medical officer at Onigbongbo Primary Health Centre.

Speaking at the event, Omaruaye said New Heights, as a responsible corporate entity, is delighted to identify with the community in their time of need, adding that the company’s expectation is that the materials donated would not only help to put smiles on the faces of the members of the community but also improve healthcare delivery in the state.

Omaruaye also revealed that the company was complementing the donations with a three-day health screening programme for traders, which would involve blood pressure checks, blood sugar checks, free malaria and pregnancy tests and a host of other medical tests.

Receiving the items, the Onigbongbo Local Government medical officer, Dr (Mrs) Folashade Tawak, expressed her gratitude to New Heights Pharma for the gesture, noting that the donation would go a long way in improving the health of the people

Also speaking, Oba Olusegun Adeyemi praised the company for its magnanimity and urged other corporate bodies in the community to emulate the good example set by New Heights.

Items donated at the event included: 3.4 KVA generator, Omron blood pressure monitors, oxygen cylinder, infrared thermometers, hand gloves, face masks, methylated spirit, among others.

NARD Laments Rates of COVID-19 Infection, Fatality Among Health Workers

1

…Urges Nigerians to take precautions

As the second wave of COVID-19 continues its ravages, the National President of National Association of Resident Doctors of Nigeria (NARD), Dr Uyilawa Okhuaihesuyi, has lamented the rates of infection and fatality among health workers, including members of his association, describing the new wave as frightening.

Okhuaihesuyi told Pharmanews in a recent interview that as of February 9, 2021, about 1500 members of his association had been infected, adding that the association had lost about 17 members to the pandemic, including a 32-year-old doctor, who died on 8 February.

Dr Uyilawa Okhuaihesuyi

He said: “We are not really happy about the spread of the virus. We have been educating our people on what the second wave of COVID-19 is and ways of preventing getting exposed to the infection. We have been advocating for more personal protective equipment (PPE). We have also been insisting that thorough screening should be carried out on individuals coming to the hospitals and those coming to our headquarters.”

He therefore call on all health workers, especially members of NARD across the country, to take utmost caution by using PPE and avoiding unnecessary contact with infected people

The NARD president further called for the setting up of more isolation centres across the country to so as to accommodate more patients.

“Government should set up more centres at various locations across the country. The number of infected people is increasing; so there is need for more centres because nobody knows when the number will go down.  More PPE should also be made available to health workers. There should also be more sensitization,” he pleaded.

Dr Okhuaihesuyi also expressed concern that some Nigerians are still skeptical about the reality of COVID-19 in the country, despite the increasing infection and fatality.

He said: “I feel for many Nigerians that still believe in the fallacy that COVID-19 is not real. I hope such people can walk to the isolation centre at Yaba, or the National Hospital, Abuja, to see things for themselves. I am sure their doubt will fly away if they can visit the isolation centres.”

To contain the spread of the virus, the NARD president urged Nigerians to avoid crowded places and social gathering as much as possible, and also make use of PPE.

“Nigerians must take precautions,” he said. “As you go out, wear your mask, wash your hands with water and soap in a running water; and in the absence of water and soap, use hand sanitiser.

“Keeping social distance is ultimately very important. If we can all take responsibility, we can contain the spread,”Dr Okhuaihesuyi said.

 

Our Personality of the Month is Pharm. Sola Solarin

1

Sola Solarin is the founder and managing partner, Savante Consulting Limited, a consultancy business servicing the pharmaceutical industry and other sectors, in providing commercial strategy consultancy, pharmaceutical products regulation, clinical research management and pharmacovigilance.

He was recently appointed president of the Industrial Pharmacy Section (IPS) of the International Pharmaceutical Federation (FIP), to coordinate the affairs of the Federation for the next four years.

Born on 8 February 1965, Solarin had his elementary and secondary education in the western part of Nigeria, after which he got admission into the Obafemi Awolowo University (OAU) to study Pharmacy in 1983. He bagged his Bachelor of Pharmacy degree in 1986. He also has an MBA from the IESE Institute of Graduate Management Education, in Barcelona, Spain.

His career in the pharmaceutical industry started in 1989 with the then Glaxo Nigeria Ltd, as a medical representative. He retired ten years later in 1999 after stints in product development, logistics and site services.

Pharm. Sola Solarin

In 2001, he led a four-man team of investors to acquire the assets of a pharmaceutical company in liquidation to form Food and Pharma Nigeria Ltd. He was the chief executive officer of the company for four years.

As a dynamic professional, he managed a pharmaceutical product development and marketing company, named Coriander Resources Limited, between 2004 and 2012. The company developed and successfully introduced into the Nigerian market four prescription medicinal products in the anti-infective, cardiovascular and musculoskeletal categories. Under his watch, the company had competencies in market research, manufacturing processes, product regulation and sales.

Solarin, as a student, was the public relations officer (PRO) of the OAU local chapter of the Pharmaceutical Association of Nigeria Students (PANS). He was also national chairman of Nigerian Association of Industrial Pharmacists (NAIP) between 2003 and 2005. He was named an eminent person of the association in 2006.

Solarin has been an active member of FIP for over ten years. He served for seven years as vice-president of the Industrial Pharmacy Section within the period, which explains his recent appointment as the president of the IPS. He rolled out the quarterly webinars of the section, which other sections have also adopted.

Solarin, is the author of the book, “The Start-Up Entrepreneur: An Emerging Market Experience.” An avid lover of water sport, he is a keen sailor as a member of the Lagos Yacht Club. He is married with children.

First Vaccine Dose Reduces COVID-19 Transmission, Hospitalisation –UK Studies

2

Data from two separate studies published in the United Kingdom on Monday, one in England and another in Scotland, have shown vaccines against COVID-19 are effective in cutting disease transmission and hospitalisations from the first dose.

Analysis from Public Health England has shown the vaccine manufactured by Pfizer-BioNTech reduces the risk of catching infection by more than 70 per cent after a first dose. That risk is reduced by 85 per cent after a second dose.

The public health body’s study of real-world data also showed vaccinated people who go on to become infected are far less likely to die or be hospitalised.

First vaccine dose reduces COVID-19 transmission, hospitalisation –UK studies

Hospitalisation and death from COVID-19 are reduced by over 75 per cent in those who have received a dose of the Pfizer-BioNTech vaccine, according to the analysis.

“This crucial report shows vaccines are working – it is extremely encouraging to see evidence that the Pfizer vaccine offers a high degree of protection against coronavirus,” Health Secretary, Matt Hancock said.

Britain is one of the countries hardest-hit by the COVID-19 pandemic, with 120,757 deaths. 

It was the first nation to begin mass vaccinations in December and more than 17 million people have now received at least a first vaccine dose – one-third of the UK’s adult population.

“We will see much more data over the coming weeks and months but we should be very encouraged by these initial findings,” Dr Mary Ramsay, Head of Immunisation at Public Health England, said.

At the same time, a study in Scotland has shown the Pfizer-BioNTech and Oxford-AstraZeneca vaccinations have led to a reduction in COVID-19 admissions to hospitals after a first dose.

The study, led by the University of Edinburgh, found that by the fourth week after receiving the initial dose the Pfizer vaccine reduced the risk of hospitalisation from COVID by up to 85 per cent.

The Oxford-AstraZeneca vaccine reduced the risk by 94 per cent.

“These results are very encouraging and have given us great reasons to be optimistic for the future,” Professor Aziz Sheikh, who lead the research, said in a statement.

“We now have national evidence — across an entire country — that vaccination provides protection against COVID-19 hospitalisations.

“Roll-out of the first vaccine dose now needs to be accelerated globally to help overcome this terrible disease,” he added.

The research compared the outcomes of those who had received their first jab with those who had not.

It found that vaccination was associated with an 81-per cent reduction in hospitalisation risk in the fourth week among those aged 80 years and over when the results for both vaccines were combined.

The project, which used patient data to track the pandemic and the vaccine roll-out in real-time, analysed a dataset covering the entire Scottish population of 5.4 million between December 8 and February 15.

Some 1.14 million vaccines were administered to 21 per cent of the Scottish population during the period.

The Pfizer vaccine was received by 650,000 people in Scotland, while 490,000 had the Oxford-AstraZeneca vaccine.

It is the first research to describe the effect of vaccinations on preventing severe illness resulting in hospitalisation across an entire country.

Previous results of vaccine efficacy have come from clinical trials.

The study team said the findings were applicable to other countries using the Pfizer and Oxford-AstraZeneca vaccines.

The data reported “is extremely promising,” said Arne Akbar, the president of the British Society for Immunology.

“Although there does seem to be some difference in effectiveness levels measured across age groups, the reduction in hospitalisations for the older age groups is still impressively high,” he said.

“We now need to understand how long-lasting this protection is for one dose of the vaccine.”

(AFP)

New COVID-19 Variant B125 Discovered in Nigeria, 15 Other Countries

2
  • Not a variant of concern yet -NCDC

The Nigeria Centre for Disease Control says that a new variant of COVID-19 has been detected in Nigeria and 15 other countries.

The new strain, B.1.2.5, which is different from the highly infectious B.1.1.7 has, however, not been described as a variant of concern yet.

Disclosing this at the Presidential Task Force on COVID-19 briefing on Monday in Abuja, NCDC Director-General, Dr. Chikwe Ihekweazu, said that researchers and scientists were still working hard to understand if the variant had any effect on the virus’ transmissibility, immunity, as well as diagnostics, vaccines and therapeutics.

“As we shared, a total of 54 cases with the B.1.1.7 variant strain, which is a variant of concern first described in the UK, have been detected in Nigeria.

“There is a new variant, the B.1.2.5, which we have begun to detect in Nigeria and 15 other countries. It is important to note that this variant has not been described as a variant of concern yet.

“Researchers and scientists are still working hard to understand if this variant has any effect on the virus transmissibility, immunity, as well as diagnostics, vaccines and therapeutics.

“This is because the variant has some similar mutations with the B.1.1.7, B.1.351 and P.1 variants first detected in the United Kingdom, South Africa and Brazil, respectively.”

The NCDC boss stated that the agency was scaling up its sequencing capacity to have a better understanding of the burden of variants of concern in the country.

He noted, “Last week, we sent another 100 samples to our colleagues at the ACEGID lab in Ede, and we did 30 sequences in our lab at NCDC.

“We will continue to scale the weekly number of samples sequenced as part of our surveillance.”

According to him, the risk of virus mutation is higher when there is high transmission of the virus.

“While sequencing is important for us to understand the situation, handwashing, physical distancing and the proper use of face masks are very important to prevent the spread of the virus,” he further stressed.

(NAN)

Correct statements concerning cocaine include all of the following EXCEPT:

5

Correct statements concerning cocaine include all of the following EXCEPT:

a) Cocaine is often used for nose and throat procedures

b) Limited use because of abuse potential

c) Myocardial depression and peripheral vasodilatation

Nourish Yourself With Aloe Vera, the Miracle Plant

1

This is a continuation of our last discussion on boosting our immune systems, in order to be fortified against attacks to our health. We are aware about the second phase of COVID-19 and every day, we hear updates on the number of new cases being reported.

Our strategy remains prevention rather than cure. We will begin by talking about certain natural products that nature has already provided around us.

Our spotlight today is on aloe vera.

Aloe vera is a plant that evolved from the lilac family, of which garlic is also a member. It contains great curative and nutritive properties. Aloe vera has regenerative properties and is even mentioned in the Holy Bible as planted by God (see Numbers 24:6, Psalm 45:8, Proverbs 7:17, Songs of Solomon 4:14). It is also said, in ancient Egyptian hieroglyphics, to have been carried by Alexander the Great on his conquests, as the only palliative for bruises and injuries.

There are over 400 species of aloe in existence. However, the one that has the greatest nutritional and therapeutic properties is the aloe vera barbadensis. Aloe is uniquely called a miracle plant or miracle healer, and is found in every part of the world.

Nourish Yourself With Aloe Vera, the Miracle Plant
Nourish Yourself With Aloe Vera, the Miracle Plant

The Aloe vera plant contains its greatest nutritional properties at two to three years of age. The succulent aloe vera is obtained from within the leaves, which is obtained by removing the peel or skin, leaving a slimy, sticky, gelatin-like tissue, containing tremendous medicinal properties.

The alow gel cannot be exposed to the elements for more than two hours, since it tends to oxidise easily, thus losing some of its therapeutic properties. It must undergo a stabilisation process to keep it maximally effective.

For consumer protection globally, there is an international independent body known as International Aloe Science Council that was established in 1981 to set standards in order to control the quality of the products and regulate the practice of the aloe industry. The council is to ensure purity of aloe products and the integrity of the manufacturing companies, as well as helping consumers make wise choices. It has its seal on every aloe vera product it approves.

However caution must be taken before ingesting any aloe plant around. It may be safe for topical application but poisonous if ingested.

Some properties of aloe (barbadensis) vera are highlighted below:

It is a complete food that meets all body nutritional requirements.

It is a pain inhibitor. Upon application to the affected area, it reduces pain. It has ability to penetrate deep layers of skin; blocks pain, penetrates and eases inflammation.

Anti-inflammatory, anti-allergenic. Aloe vera works in a way similar to steroids, like cortisone, but without the harmful side effects. It contains glycoproteins, anthraquinones and salicylates. Aloe is very helpful in healing skin abrasions and burns because it contains magnesium lactate. It is very effective against arthritis and insect bites. Aloe does not contain cortisone, but has enzymes and other elements which work extremely well in relieving soreness in affected areas.

Healing action: Aloe Vera has very high levels of calcium, potassium, zinc, as well as Vitamin C and E. These minerals promote the formation of a net of fibres that trap the red blood corpuscles, thus speeding up the healing process. Calcium is a very important element in the proper function of the nervous system.

Detoxification: Aloe detoxification is a combination of elimination, regeneration and assimilation. Due to the potassium which it contains, aloe vera improves and stimulates the liver and the kidneys, the principal organs of detoxification. Aloe vera contains uronic acid which eliminates toxic materials within the cells. The first time aloe vera is ingested, it tends to cause a slight case of diarrhoea because it causes an initial cleansing of the intestines from bacteria as well as from food stuck in the folds or in the diverticulum.

To be continued.

Mrs Chima Ejimofor is the lead partner at Infinite Health Consult. She is available for health and wellness products, seminars and talks. She is based in Lagos, Nigeria. Telephone/WhatsApp: 07033179632, email infinitehealthconsult@gmail.com

Ignorance, Major Factor in COVID-19 Spread – Nursing Director

1

Ignorance has been identified as a key factor in the spread of the deadly COVID-19 pandemic, as many people are yet to believe in the existence of the infection, causing them to move about without adherence to safety protocols.

Mrs Christianah Olusola Ayeni, director of nursing services (DNS), Lagos State Primary Healthcare Board (LSPHCB), made this disclosure in a recent interview with Pharmanews, noting that in spite of various community sensitisation programmes embarked upon by the Board and even the Lagos State Government, most community members have shunned routine visits to the primary healthcare centres for the treatment of their ailments.

Ignorance, Major Factor in COVID-19 Spread – Nursing Director
Mrs Christianah Olusola Ayeni

She added that many people now resort to self-medication, which usually leads to late presentation when they visit the hospital.

While acknowledging the efforts of government in training nurses and health workers on infection prevention, she asked that this be intensified, as well as the provision of more personal protective equipment. Below are the excerpts:

With nurses at the frontline of the battle against COVID- 19, how has it been for nurses at the Primary Healthcare Centres (PHCs)?

Professionally speaking, anyone with the knowledge of healthcare service delivery can explain the intricacies involved, and the hazards of the profession. There’s the need for health service providers to be passionate about their jobs, whether it is on the high or low side and no matter the intensity involved. This is why, during any challenge, pandemic or epidemic, nurses are always prepared.

Nurses at the primary healthcare level have been rising to the occasion. For instance, we have been doing all our best to face the challenges as they arise, starting from training of nurses and all health workers on COVID-19 and to strict adherence  to infection prevention protocols in all our facilities.

Furthermore, the Lagos State Primary Healthcare Board (LSPHCB) has put in place, mobilisation, sensitisation and health education in the communities for awareness creation about the infection.

We also give daily health talks in all our PHCs on COVID- 19 symptoms, most importantly the prevention and strict adherence to its safety protocols.

Hand washing sites in all our PHCs were created towards ensuring clients and patients perform hand washing procedure before entering the PHC.  We also ensure that all patients put on face mask.

 

In what ways has the pandemic affected nursing care at the health centres?

Despite the fact that all nursing services were put in place during the pandemic, we experience low turnout of patients, resulting in drastic reduction in earlier recorded statistics.

Ignorance on the part of some community members also contributed to the low effects of nursing care. This is because despite all the noise and sensitisation by the agencies of government (including Primary Healthcare Board mobilisation) and even by our governor, the incident commander, many people do not still believe that COVID- 19 exists. So, instead of coming to the health facility for treatment, they take to traditional therapies at home, thereby reporting at the health facility when the case becomes worse.

 

Doctors and pharmacists have been updating the public about infected members but much has not been heard about infected nurses. Does it mean that nurses are not infected?

No, that assertion can be wrong. This is because we have had cases of nurses being infected with COVID- 19 during the course of discharging their duties. For instance, some cases of infected nurses were reported during the first wave of the pandemic by the National Association of Nigeria Nurses and Midwives, Lagos State Branch, at the level of primary, secondary and tertiary healthcare facilities.

 

Has the PHCB recorded any fatality among nurses?

No, there hasn’t been any record of such at the PHC level. Those affected are always going to the isolation unit and come back recovered.

 

With 9,856 active cases of COVID-19 currently in the community as stated by the Lagos State Government, how does the Board ensure that majority of them receive nursing care?

In collaboration with the state government, PHCB has trained health workers, including nurses in preparation for home-based care of COVID-19 mild/ asymptomatic cases.

So, let me assure you that the Lagos State government with the PHCB has put in place a robust plan with high efficacy and efficiency that will take care of asymptomatic/mild cases that have been screened for either isolation unit or home-based-community care.

 

On the part of the Board, what are the strategies put in place to mitigate spread of infection among nurses?

All nurses and health workers have been adequately trained on COVID- 19 signs and symptoms and the various aspects of prevention.

In addition, the use of PPEs, hand washing procedures, social distancing at the PHC, avoiding crowds by giving staggered appointment procedure to clients have all been put in place.

Triaging protocols are also in place at the general outpatient department as patients are coming in. Strict adherence to infection prevention protocols by nurses and all health workers is also enforced.

 

Going forward, how can nurses be strengthened to overcome the pandemic?

In addition to all that has been mentioned above, there’s need for continuous training and retraining of nurses on infection prevention protocols. Also, supervision and monitoring by the PHCB to ensure strict compliance to COVID-19 prevention protocols at the facility level is required.

Moreover, governments need to provide adequate PPEs in all our Primary Health Care facilities for proper protection of nurses and health workers.

Nurses should be adequately informed by encouraging them to be aware of what is going around them through news update and government directives on COVID- 19.

They can also be strengthened through motivation and empowerment by the government and partner agencies.

Pharmacity Project: Dawn of an Anticipated Revolution 

1

During a recent interview which was monitored by Pharmanews, Registrar of the Pharmacists Council of Nigeria, Pharm. (Dr) NAE Mohammed made a poignant observation that echoed the concerns of every other stakeholder in the Nigerian pharmaceutical landscape. According to him, “The Nigerian pharmaceutical sector today is still very much import-dependent, which is a threat to the security and health of Nigerians. Because of that we need a revolution to make us look inward and be able to have total control over the pharmaceutical landscape of this country.”

This much anticipated “revolution” seems to be rapidly coming to manifestation with the recent unveiling of West Africa’s premier pharmaceutical park in Ebonyi State. This landmark initiative, modelled along Alfred Weber’s celebrated theory of industrial location, is a brainchild of the Association of Industrial Pharmacists of Nigeria (NAIP), led by Pharm. Ignatius Anukwu and Bloom Public Health, led by Professor Chimezie Anyakora. According to a statement released by the initiators, the Pharmacity project was conceived to tackle the existing challenges of infrastructure, high cost of manufacturing and revolutionise indigenous drug manufacturing.  They added that the park is categorized into five zones – namely, the industrial zone, the shared services zone, the supply services zone, the games and recreation zone and the residential zone.

Altogether, the park is projected to provide, among other features, state-of-the-art facilities, including factories with access controls for secure production; warehouse facilities for raw materials and finished products; an administrative block that will provide office spaces for regulatory agencies; a research and development centre that will serve as a converging point for researchers from across the globe; as well as a training centre that will provide continuous capacity building for staff of companies within the park.

We commend the initiators of this project, as well as the laudable objectives behind their revolutionary vision. Indeed, if all the plans of the initiators are fully implemented as projected, there will be such phenomenal transformations in the Nigerian pharmaceutical space that will bring maximum benefits to not just the pharmaceutical manufacturers but all other stakeholders and the Nigerian nation as a whole. There is no doubt that the equipment and other facilities within the shared zone will not only guarantee efficiency but will also drastically cut the cost of manufacturing for companies at the park, by providing economies of scale.

Moreover, as Dr Obi Adigwe, director general of the National Institute for Pharmaceutical Research and Development (NIPRD) has aptly observed, “When you have a value chain of different stakeholders all aggregated in the same place, then it is easier to identify the needs of the entire value chain and then develop contextual research and development solutions that can help to address those needs.” Indeed, this collaboration of NAIP and Bloom Public Health in the Pharmacity Project will undoubtedly add value to the Nigerian pharmaceutical space and positively impact on pharmaceutical manufacturing in the entire West African sub-region.

It must be added, very importantly, that this initiative will not only ensure that local pharmaceutical manufacturers are empowered to produce high quality medicines that will comply with GMP guidelines, but will also reduce cost of medicines since  the raw materials and other production factors will be sourced locally. With this, Nigerians and citizens of neighbouring West African countries can easily access quality medicines at affordable prices.

Also worthy of note is that the unveiling of the project in Ebonyi State is just the beginning as many other states will definitely key into the project and establish similar parks in their domains. The Governor of the state, Engineer David Umahi, indeed deserves commendation as he ensured that the unveiling was bolstered with the donation of one hundred hectares of land for the project. He also went further to perform the groundbreaking ceremony in company of the President of the Pharmaceutical Society of Nigeria, Mazi Sam Ohuabunwa.  The implication of this is that sooner than later, the Nigerian pharmaceutical landscape and the health sector, in general, would have been positioned to compete with their counterparts in any part of the world.

Additionally, the Pharmacity Project will also help to tackle the challenge of unemployment to a large extent. One can imagine the multiplier effect of establishing pharmaceutical parks in all the 36 states of the federation. The effect on job creation and increased revenues for the states cannot be overemphasised. Moreover, the establishment of these parks will also come with special power supply plans which, in effect, would improve electricity in these areas.

In terms of infrastructural development, the pharmacity project would definitely catalyze Nigeria’s industrialisation reputation. It is a project that all stakeholders in the health sector should support. Soon other African countries will adopt the model and continue to look onto Nigeria as a nation of innovators who would never cease to be relevant in the entire world’s quest for a vibrant health care system. We hereby call on all state governments and all stakeholders in the health sector to support this laudable project by allotting land and funds for its takeoff in their respective states.

We call on the leadership of NAIP and Bloom Public Health to, as a matter of urgency, sustain the tempo of their collective advocacy towards the full actualisation of this project. It is a treasure that is capable of obliterating the not-too-palatable impression the world has had about the Nigerian health sector.

NHIS to Establish Fund for Treatment of Cancer, Heart Disease

1

The National Health Insurance Scheme is to establish a National Catastrophic Fund to specifically address terminal ailments such as cancer, advanced heart disease, among others.

The Executive Secretary of the scheme, Prof. Mohammed Sambo, disclosed this at the News Agency of Nigeria Forum in Abuja on Sunday.

He said that the current contribution to the health insurance pool was insufficient to cater for some packages and programmes of the scheme.

He emphasised that if NHIS had enough funds, it would cover the treatment and management of cancer and other terminal diseases fully.

“But we will not leave our people to be afflicted. We are creating another initiative – the Catastrophic Fund, within the NHIS.

“Some international agencies have indicated willingness toward that and other partners like the World Bank trying to ensure that we establish the fund.

 “So, when we have the contributions, we can move from limited coverage to advanced coverage, depending on how much is contributed into the fund.”

Sambo also said that the scheme was planning to invest its residual fund, saying: “if we are allowed to invest our money by the office of the accountant general, we will be able to get more funds.

“We cannot say that we have enough funds when we cannot cover cancer; it doesn’t add up.

 “If you go by our own conservative calculations as to our mandate of covering 200 million Nigerians and if you are to look at the basic payment under Group Individual and Family Social Health Insurance Programme which is N15,000 per annum, we cannot cover everything.

“Multiplying N15, 000 by 200, 000,000 people will amount to N3 trillion to cover entire Nigeria; which means we need about N3 trillion at the rate of N15,000 per head to cover the entire nation.

“We certainly do not have enough funds, but we are thinking of innovative financing mechanisms.”

The NHIS chief reiterated the determination of the organisation to generate more funds to health insurance coffers for the coverage of all Nigerians.

Sambo told NAN that the GIFSHIP would allow more people to benefit from health insurance, adding that the scheme had other initiatives for Nigerians.

He announced that plans to extend health insurance coverage to the elderly and retirees had also reached an advanced stage, noting that the move was to reduce out-of-pocket health expenditures on the people.

He noted that the reforms and initiatives embarked upon by the scheme was steering it toward the attainment of Universal Health Coverage, where Nigerians would access quality healthcare without financial hardship.

He explained that money contributed to the scheme was never a waste even if the enrollee did not fall sick.

He said “in insurance, the contributions of some enrollees would be spent on others even if the contributors didn’t go to the hospital.

“So, the philosophy of insurance is that you contribute on the basis of solidarity; you have contributed but because you are well, the money would be used for others.

“That is the basic philosophy behind the NHIS system,” the executive secretary said.

(NAN)

COVID-19 Expected to Last Long-Term Despite Global Vaccine Rollout

1

The head of the European Union’s disease control agency has warned that the novel coronavirus could last indefinitely even as global infections slowed by nearly half in the last month and vaccine rollouts gathered pace in parts of the world.

In an interview with AFP, ECDC chief Andrea Ammon urged European countries in particular not to drop their guard against a virus that “seems very well adapted to humans” and may require experts to tweak vaccines over time, as is the case with the seasonal flu.

“So we should be prepared that it will remain with us,” according to Ammon, head of the Stockholm-based European Centre for Disease Prevention and Control.

Ten Myths about Coronavirus Debunked by WHO

After the latest harsh wave of a pandemic that started in China more than a year ago, glimmers of hope flickered as an AFP database showed the rate of new COVID-19 infections has slowed by 44.5 per cent worldwide over the past month.

More than 107 million people have been infected worldwide and nearly 2.4 million have died from COVID-19.

But disease experts warned that vaccines won’t end the pandemic unless all countries receive doses in a fast and fair manner.

Writing in an open letter published in The Lancet medical journal, the authors said with vaccine stockpiling in wealthier countries, “it could be years before the coronavirus is brought under control at a global level.”

The warning came as US vaccine maker Moderna said it was seeking clearance with regulators around the world to put 50 per cent more coronavirus vaccine into each of its vials as a way to quickly boost current supply levels.

In Britain, a marked drop in infections and accelerating vaccinations have prompted some within the governing Conservative Party to push for stay-at-home rules to be lifted in early March.

Much of the country re-entered lockdown in early January to curb a more transmissible COVID-19 variant first identified in the UK.

The British government nonetheless voiced caution, a watchword echoed elsewhere, including Italy, Portugal and Australia.

In Australia, more than six million people in Melbourne and its surrounding area were under an emergency five-day coronavirus lockdown.

“It’s rough. It’s going to be a rough few days for everyone,” said tennis star Serena Williams, reacting to the lockdown moments after her latest victory at the Australian Open.

While the play will continue under the restrictions, fans will no longer be permitted and players must restrict themselves to biosecure “bubbles”.

The toll on sports, entertainment and economies continued to be massive. 

The Tokyo Olympic Games are due to open in July after multiple delays.

But the games organisers are already battling public misgivings about holding the huge international event this summer.

European Commission chief Ursula von der Leyen urged the 27 EU member countries to accelerate the ratification of a key part of the bloc’s 750-billion-euro ($900-billion) plan to recover from the impact of the pandemic.

The UK – which has left the EU and has Europe’s highest virus death toll after a heavily criticised initial response to the pandemic – reported that the economy shrank a record 9.9 per cent last year.

Finance minister Rishi Sunak admitted the impact would be a “serious shock” and warned: “We should expect the economy to get worse before it gets better.”

Hungary meanwhile said it will become the first EU nation to start using Russia’s Sputnik V vaccine.

The country broke ranks with the EU last month by becoming the first bloc member to approve Sputnik V, ordering two million doses to be delivered over three months, enough to vaccinate one million people.

Russia registered Sputnik V in August, months ahead of Western competitors but before the start of large-scale clinical trials, which left some experts wary.

However, recent results published in The Lancet found that the vaccine is 91.6 per cent effective against COVID-19.

Some EU leaders seem to be warming to the idea of deploying Sputnik V as the bloc struggles with supply shortfalls for the three vaccines it has approved. 

The European Medicines Agency has so far approved vaccines for the bloc developed by US-German firm Pfizer-BioNTech, US firm Moderna and British-Swedish firm AstraZeneca with Oxford University.

The EMA said Friday it had started a “rolling review” of a vaccine from German manufacturer CureVac, the first step towards possible authorisation.

In the United States – the world’s hardest-hit country with more than 480,000 deaths – health authorities on Friday urged schools to reopen safely and as soon as possible, offering a detailed plan for limiting the spread of COVID-19.

The strategy emphasizes universal masking, handwashing, disinfection and contact tracing. While recommending vaccination for teachers and staff, it stops short of saying it is necessary — a divisive issue among teachers’ unions.

The push comes as the United States is in the midst of an aggressive mass vaccination campaign, intending to inoculate nearly all Americans by the end of July.

Hard-hit Brazil’s drive to vaccinate its population has stumbled this week as a lack of doses forced authorities to slow or halt immunisation in several key areas.

But Prime Minister Justin Trudeau said Canada’s COVID-19 vaccines rollout will be back on track in March with stepped up deliveries of doses to make up for recent delays.

(AFP)

‘Pfizer Vaccine 95.8% Effective Against COVID-19’

1

Israel’s health ministry says recent data from its aggressive coronavirus vaccination campaign showed two doses of the Pfizer/BioNTech vaccine were nearly 96 per cent effective against infection.

Israel’s inoculation campaign is regarded as the world’s fastest, with one dose of the Pfizer/BioNTech vaccine administered to 4.25 million people out of its nine million-strong population since December, according to the latest health ministry figures.

Some 2.88 million people have received the recommended full course of two jabs.

The health ministry said on Saturday that the vaccine had proved 95.8 per cent effective in preventing coronavirus infection among those vaccinated two weeks after receiving their second shot compared to unvaccinated people, according to data compiled up to February 13.

It added the jab was 99.2 per cent effective against serious illness and 98.9 per cent effective in preventing death.

For those tested one week after receiving a second jab, the vaccine was 91.9 per cent effective against infection, 96.4 per cent effective in preventing serious illness and 94.5 per cent in preventing death.

“Our goal is to continue vaccinating all our population aged 16 and up, to reach a wide coverage of the population that will enable us to return to our much-missed routines,” health ministry director-general Hezi Levi said in a statement Saturday.

The jab developed by US pharma giant Pfizer and its German partner BioNTech is based on novel mRNA technology and was the first vaccine against COVID-19 to be approved in the West late last year. 

Israel, which has one of the world’s most sophisticated medical data systems, secured a substantial stock of the Pfizer/BioNTech vaccine by paying above market price and by striking a data-sharing deal with the US company.

(AFP)

521 New COVID-19 Cases, Eight Deaths Recorded Across 19 States, FCT

0

The Nigeria Centre for Disease Control has registered 521 new cases of COVID-19, bringing the total number of infections in the country to 152,074.

The NCDC disclosed this on Sunday on its official Twitter handle.

The News Agency of Nigeria reported that the country’s daily COVID-19 infection rate has dropped below 1,000, for the fifth consecutive day.

The public health agency said it has tested 1,441,013 people since the index case was announced on February 27 last year.

On Sunday, the NCDC recorded eight new COVID-19-related deaths, raising the total fatalities in Nigeria to 1,839.

The agency noted that the new infections were reported from 19 states and the Federal Capital Territory.

According to the NCDC, the state-by-state COVID-19 infections are as follows: Lagos, Ogun, Rivers, Adamawa and Ebonyi recorded 116, 52, 47, 37, and 37 cases respectively.

Akwa Ibom had 25 cases; Osun reported 21; Bayelsa-18; Kaduna-17; Oyo-16; Ekiti-14; Kano-12 and Edo-12.

Fifteen cases of were also recorded in the FCT.

Nine cases of COVID-19 were reported in Borno; Yobe had eight; Ondo; six; Nasarawa reported four; Bauchi two; and Kwara had three cases.

The NCDC stated that 614 people have been discharged from the various isolation centres in the last 24 hours.

It noted that those discharged on Sunday included 228 community recoveries in Lagos State and 43 recoveries in Kwara, all managed in line with NCDC guidelines.

The public health agency said that the country has recorded 128,619 recoveries since the onset of the coronavirus pandemic last year.

It said that a multi-sector National Emergency Operations Centre, activated at Level 3, is coordinating response activities nationwide.

The NCDC said that there were now 21,668 active cases across the country.

(NAN)

Why There Are no Open Drug Markets in Osun State – Adebayo

0

Pharm. (Alh.) Olufemi Ismail Adebayo is a Fellow of the Pharmaceutical Society of Nigeria and former national chairman of the Association of Community Pharmacists of Nigeria (ACPN) from 2012 to 2015. In this exclusive interview with Pharmanews, Adebayo, who is the current coordinator, Board Of Fellows (BOF), PSN, Osun State, speaks on the state of pharmacy practice in Osun and beyond, his tenure as ACPN leader, his views on his successors and the impacts of COVID-19. Excerpts:

As a stakeholder in the pharmacy practice in the country, how do you see pharmacy practice today, compared to when you started?

Pharmacy profession is advancing to the glory of God. During our own days, when we were much younger, it used to be analogue, but everything has now turned digital. Especially with the emergence of COVID-19, we now have online meetings, online marketing, online purchasing and others.

I think the pharmacy profession is also falling in line. In fact, it was the advent of technology that made it possible for us to hold the just concluded hybrid PSN national conference in Osogbo, Osun State. So, you will agree with me that the profession is moving with time, and gone are the days when everything used to be analogue.

Today, with technology, buyers may not necessarily have to travel several miles before accessing our products, which is an improvement on how it was before.

 

As somebody who is based in Osun State, what is your assessment of community pharmacy practice there?

We are happy that we don’t have open drug markets here in Osun, and thanks to the government for that. I also want to appreciate the Pharmacists Council of Nigeria (PCN), and the Pharmaceutical Inspectorate Committee (PIC), for the wonderful job they are doing in the state.

The PIC has been working as a group to rid the state of illegal premises, and by virtue of that, there is a level of sanity as far as pharmacy practice is concerned in the state, as against what is obtainable in some states. It is not that the state is hundred per cent free of illegal premises and charlatans, but to a great extent, pharmacy practice is having it good here.

 

Are there challenges peculiar to practising in Osun State?

We cannot rule out challenges completely, as there is bound to be one. Some of the challenges, just like we have it everywhere else, include; medical practitioners doing the job of prescriber and dispenser at the same time, the health insurance schemes at both state and national level not carrying the pharmacists along, as well as charlatans competing with the professionals.

 

You were the ACPN national chairman six years ago, would you say you are satisfied with the ACPN you left in 2015?

I am highly impressed with the state of ACPN today, compared to how I left it six years ago, and I must commend my immediate successor, Dr Albert Kelong Alkali, for building on the structure that we had on ground. I must also appreciate the person that took over from him too, Dr Samuel Adekola, for not letting the guards down.

One of my dreams for the ACPN was to have a building of our own, but because of the financial status of the association then, we couldn’t realise it. Still, we were able to save some amount of money for that purpose, with the intention that the incoming administration would continue from there. And truly to our expectation, the tenure of Dr Alkali realised that dream by purchasing, renovating and commissioning a building in a prime area of Opebi, in Ikeja.

I also want to commend his own successor too, in the person of Pharm. Samuel Adekola for sustaining the tempo and for bringing the association to limelight.  You would recall that when I was the chairman, we did a lot in the aspect of publicity and projecting the image of the association. The media partnership we had with Pharmanews especially was strategic and it yielded  positive results.

Likewise, the current administration has been doing a lot, and it gives me joy that the structure we had then has been built on and sustained. In fact, the current leadership has been able to acquire an official car for the association, which is an additional improvement.

 

Moving forward, if you are to advise the current crop of leadership of the ACPN, what would you say?

Dissemination of information is very key, and if people don’t have adequate information as and when due, it gives rooms for rumour-mongering among members and when this happens, it may cause misunderstandings, and even good ideas may be misrepresented.

I want to also advise them to consult wide before taking any decision, so that everybody would be on the same page. If they consult wide, irrespective of the distance – Rivers, Kano, Jigawa and others – there would be one voice. Even though some may still have objections, the majority would have been carried along, which is better for the growth of the profession and the association. It is necessary that we have good dissemination of information and it should be done at the appropriate time.

 

What is your advice to the young ones who want to go into community practice?

My advice is, whatever one is doing, do it well. Also, consistency is what wins the race; so they should be consistent, make themselves known, and they should know what they are doing. They should not go beyond their boundary; they should make referrals, if there is need for it.

Breast Cancer Survivors Seek Better Advocacy, Support From Government

0

“We should stop wallowing in self-pity. If we don’t tell the government what to do, it’s a waste of time. We should target the right audience.” So says Ms Della Ogunleye, a breast cancer survivor, who knows where it hurts and the right intervention needed.

The World Health Organisation, (WHO) in its latest report on global cancer burden says breast cancer has overtaken lung cancer as the leading cancer in the world with an estimated 2.3 million new cases out of 19.3 million global cancer cases diagnosed in the year 2020.

Nigeria’s breast cancer profile, as presented by the WHO aligns with the global incidence as recent statistics shows a mortality rate of 16.4 per cent out of the 22.7 per cent prevalence in 2018. It is also projected that more cancer cases will be diagnosed in the nearest future to the tune of 50 per cent increase in 2040 than in 2020.

Breast Cancer Survivors Seek Better Advocacy, Support From Government
Breast Cancer Survivors Seek Better Advocacy, Support From Government

Hence, the decision of survivors is very apt to prevent a very bleak future filled with groaning and misery of helpless patients at the hands of the deadly disease.

 

Global consciousness

Usually commemorated on 4 February of every year, for the singular purpose of awareness creation and advocacy, the World Cancer Day was established in 2008 by the Union for International Cancer Control (UICC) to enlighten people on cancer and to conduct screening for citizens to know their status regarding  the condition.

The World Cancer Day also particularly affords breast cancer survivors the golden opportunity of telling their stories to encourage those going through or about to undergo mastectomy.

 

Cases

Ms Della Ogunleye, CEO, DDS African Cancer Support Group based in the UK, is one of the gallant amazons who beat breast cancer. Since she had no deep knowledge of the disease when she was diagnosed in the UK, she felt it was one of those things she could ignore and continue with her busy schedule as usual, but alas, she was slown down by the draining disease.

She never exhibited any sort of fear when diagnosed, as she assured herself of living her life to the fullest. She informed her confidants about the development and she was advised to go for medical attention, and fortunately, it was removed successfully because it was diagnosed early.

“If they had told me what the side effects of the treatment would be, that would have scared me. In the course of the treatment, I lost appetite. I lost my hair, I lost friends because the journey was terrible with the treatment. It was the support group that helped me cope with the psychological effect of losing a breast,” she narrated.

It was a different ball game for Solumkolia Obi-Anazodo, who shivered at the disclosure of her diagnostic result in 2018. “I was having a shower when I felt a lump in my breast”, she revealed. Initially, she paid less attention to it, thinking it would disappear with time, but it didn’t. The lump continued to grow and when it was examined, it turned out to be a cancerous lump; in fact, a stage 3 cancer of the breast.

“At first, I wasn’t scared. My mind didn’t even go to cancer. But when I got the report of my breast cancer, fear crept in,” Obi-Anazodo said.

Thereafter, she became an advocate like Ogunleye and others who would leave no stone unturned in seeking help for patients.

For optimal healthcare outcome to be obtained in cancer cases, Ogunleye urged patients to seek help as soon as they notice any strange development on their body – “whether on your breast, skin, or in your urine, it is important you get it checked, because it’s all about early detection”.

Ogunleye also emphasied the need for care and support from government and family members, even as she condemned the idea of self-pity which, she said will only worsen the situation.

“When you are diagnosed with cancer, you need support. Somebody has to hear your voice. We should stop wallowing in self-pity. If we don’t tell the government what to do, it’s a waste of time. We should target the right audience”.

The story of the co-founder of the Bricon Foundation, Abigail Simon-Hart, resonates with Ogunleye’s call for support and care for cancer patients. Although she was fortunate to have early discovery of the tumour, as she had double mastectomy, she stressed the importance of calmness at the onset of the journey, noting that the ripple effects of fear can be overwhelming for patients.

An advocate of breast cancer, she motivates her counterparts to do away with shame about the condition, stressing that that wouldn’t help in any way, recommending instead that they speak to the right audience about the condition for a change to take place.

Her determination paid off as her case seemed almost impossible with the cancer spread across her two breasts, when diagnosed, but she was able to break out of the condition because of her doggedness to get rid of it.

She said: “I was diagnosed of breast cancer in 2014, fortunately it was discovered early. So I had a double mastectomy, which means I removed both breasts and I’m currently cancer-free, due to the fact that we got it early.

“So I’m a great advocate of cancer awareness creation. I make bold to tell anyone I’m  a cancer survivor and I’m  not ashamed about it. As long as people are afraid, it brings stigma, and as long as there is stigma, people will be unwilling to come out for screening.”

Experts have also lent their voices to the need for sufficient information on the disease, adding that this will go a long way in alleviating patients’ worries. There are several challenges which make the treatment of cancer unbearable for a huge number of patients in the country.

“They are so many, but the first and largest constraint is finance, the second is lack of infrastructure and personnel and the others include stigma, shame, and fear brought about by cultural, religious, and traditional beliefs,” said Simon-Hart.

“Cancer is a very expensive disease and many Nigerians cannot afford the treatment. A CT Scan costs about 86,000 naira, a shot of chemotherapy is between 120-180 thousand Naira and a person can take up to ten shots depending on the stage of cancer. How can an average Nigerian afford that? There is no way a person will be healed if he or she is being treated while thinking of all the debt.”

Thus, getting adequate information from a care provider and support from government are significant ways to help patients.

 

Cancer causes

Science is yet to unravel the actual cause of cancer, but scientists have some valuable insights. According to the WHO, changes in lifestyle, unhealthy diets, insufficient physical activity, use of tobacco and harmful use of alcohol have all contributed to the increasing cancer burden. A significant proportion can also be attributed to increasing longevity, as the risk of developing cancer increases with age. This reinforces the need to invest in both cancer prevention and cancer control, focusing on actionable cancers like breast, cervical and childhood cancers.

An oncology and radiotherapy resident at Lagos University Teaching Hospital, Dr Agbakwuru Chidi, has also identified lack of breastfeeding and being pregnant as established risk factors for breast cancer.

Other causes, as noted by experts, are genetic composition, hormone treatment, radiation exposure, body weight, dense breast tissue, estrogen exposure and history of breast cancer.

 

COVID-19 and breast cancer

LASUTH recently disclosed the effect of the coronavirus pandemic on breast cancer patients, saying it has exacerbated the problems of late-stage diagnosis and lack of access to treatment. These occur everywhere but particularly in low- and middle-income countries. In addition to having to cope with the disruption of services, people living with cancer are also at a higher risk of severe COVID-19 illness and death.

Agbakwuru corrobated the WHO’s view saying COVID is harder on cancer patients who already have low immunity and makes them more susceptible

A WHO survey conducted in 2020 indicated that treatment for cancer had been disrupted in more than 40 per cent of countries surveyed during the pandemic. The findings of the survey have been backed up by published studies indicating that delays in diagnosis are common, while interruptions to and abandonment of therapy have increased significantly. Meanwhile, enrolment in clinical trials and research output have declined.

This shows that more commitment is expected of the Nigerian government towards cancer care than what is stated in the National Cancer Control Plan 2018 –2022. Indeed, as of now, many of its objectives are yet to be realised barely a year to the end of the deadline.

The programme aims at achieving greater than 50 per cent screening of eligible population by 2022; and increase by at least 50 per cent the functionality of the comprehensive cancer care centres by the year 2022, among others. But hardly has any of these goals been accomplished.

 

Cure and coping strategies

Studies and survivors’ stories have validated that breast cancer can be cured if detected early and treated accordingly. The WHO’s statement on the eve of World Cancer Day 2021 underscored this as it stressed the possibility of cure for  breast, cervical and childhood cancers, if diagnosed early and treated appropriately.

“Breast, cervical and childhood cancers all have a high chance of cure if diagnosed early and treated appropriately. This World Cancer Day, WHO is moving ahead with our partners around the world in efforts both to prevent and control cancer and also to provide support to all people living with cancer, wherever they live and whatever their circumstances,” it disclosed.

 

The battle continues

Having being cured of their conditions, survivors have expressed another major challenge confronting them, which is coping with psychosocial trauma of living with one or no breast. Although the option of breast implant exists, the scare of complications often makes them jettison it.

In a study titled, “Life without a breast: Exploring the experiences of young Nigerian women after mastectomy for breast cancer”, published in the Journal of Global Oncology, participants bared their minds on psychosocial issues related to having one or both breast off.

Survivors who participated in the study revealed how they have successfully coped with this trauma years after their surgery. They explained how they intentionally developed certain strategies to help them cope psychologically. Some of the strategies employed include:  Self-acceptance, distraction, lightheartedness, and religion.

With respect to self-acceptance, a 35-year-old participant said: “Just accept yourself the way you are”. Whenever some women felt downcast, they engaged in activities that would distract them. For instance, one participant said: “At times, I would stroll out or pick up my phone”.  Being lighthearted about having had the breast removed also helped some participants.

Nutrition, Lifestyle and Intellectual Development

1

The role of nutrition in the intellectual development of humans is very crucial, right from pregnancy. This is the reason pregnant women are advised to strictly ensure that they are well-fed during this period, as whatever they eat has a strong effect on the life of the child in their womb. Undernutrition for a pregnant woman is therefore an aberration that must not be allowed to happen.

Many experts have said that adequate nutrition is vital to normal brain development. Nutrition is especially important during pregnancy and infancy, which are crucial periods for the formation of the brain, laying the foundation for the development of cognitive, motor, and socio-emotional skills throughout childhood and adulthood

The development of a child’s brain is greatly determined by the kind of food he or she eats. During childhood, undernutrition has been reported to lead to the loss of energy and interest in learning in children. This development also affects their cognitive faculties and academic performance. It also negatively affects physical growth, maturation and the child’s general wellbeing. It is therefore essential that children receive the best nutrition possible to enable them develop into healthy adults.

Mr Patrick Iwelummor

Anything that hampers the provision of adequate nutrition to a child distorts his or her mental, emotional and cerebral development. Children raised in war-torn areas, where hunger and starvation reign supreme have always shown the propensity to become disoriented and psychologically fragmented adults due to the deprivations caused by the state of their environment. They even lack good self-esteem and are always withdrawn, feeling inferior and timid. Such characteristics do not encourage the acquisition of knowledge.

Even in adulthood, the role nutrition plays is very significant. Adults who don’t have adequate nutrition, due to economic or lifestyle factors may not be able to pursue noble intellectual heights. Eating balanced diet and taking nutritional supplements have been proven to support general wellbeing and increase a person’s chances of having a strong immune system, which automatically helps him or her to ward off infections.

A healthy body is tantamount to a healthy mind. Without a healthy mind, the assimilation of knowledge is greatly threatened. Depriving our bodies of the right combination of food and mineral nutrients may lead to disease conditions that would in turn prevent us from learning and engaging in other intellectual activities.

Lifestyle factors, such as alcoholism, substance abuse and smoking are food to some people who cannot do without them. While the whole world is grappling with the challenges brought about by the sophistications of technology and human civilisation, mankind is also faced with socialisation-related challenges, which have thrown up so many aberrations that have come to be accepted as the norm.

For instance, the level of ingenuity that youths continue to demonstrate in abusing drugs will leave even some scientists and behavioural experts shocked. Clinical drugs like tramadol, codeine and Rohypnol have been converted to supplements by our youths. Alcoholic beverages are mixed with any or all of these drugs and taken. Some even use the mixture to bake cake.

The fundamental question is: how can people who consume such cocktails concentrate and have time for intellectual pursuits? They can only end up as dropouts or manage to pass through school without acquiring any meaningful knowledge. An education-related website (Study.com) highlights the damage substance abuse can do to a youth’s quest for academic excellence thus: “Substance abuse is the harmful, excessive use of drugs such as alcohol, prescriptions, over-the-counter medicine or some other type of chemical substance. Such use brings a multitude of health risks like mood swings, high blood pressure, organ damage, and lack of focus and concentration. All of these can affect your general health as well as your performance at work or school. Unfortunately, these risks are even greater for young people because their brains and bodies are still developing during the adolescent years”.

 

A couple of years back, a popular academic in one of the federal universities cut short his life in a ghastly motor accident caused by overconsumption of alcohol. Even before then, his life as an academic had been a huge struggle because his overdependence on liquor limited his chances of attaining higher pedestals in his career. Many of his associates on campus believe that he was even lucky to have reached the stage he was before he died. Their belief was based on the recklessness with which he consumed alcohol.

For all who aspire towards intellectual glory, good food, enough rest, less worry, abstinence from drugs and alcohol and above all devotion to God are the basic ingredients they need. Healthy nutritional habits and a healthy lifestyle, complemented with healthy spiritual food (the Word of God), will lead to the attainment of uncommon intellectual heights.

Study Shows Genetics Play a Role in Happy Marriage

0

Several researches have shown that people fall in love for so many reasons, to some, physical attraction, similar beliefs or interests, and to others it is the same values they share. However, a new research led by Yale School of public health researchers shows that if couples stay together for a long-term, their happiness may depend on their individual genes or those of their spouses.

The study which was published in the journal PLOS ONE, examined the role of a genetic variation that affects oxytocin, a hormone that plays a role in social bonding.

Associate professor and lead author Joan Monin, and her team studied 178 married couples ranging in age from 37 to 90 years old. Each participant completed a survey about their feelings of marital security and satisfaction, and also provided a saliva sample for genotyping.

They found that when at least one partner had a genetic variation known as the GG genotype within the oxytocin gene receptor, the couple reported significantly greater marital satisfaction and feelings of security within their marriage. Those couples had greater satisfaction compared with other couples who had different genotypes.

Image of a woman and man greatly in love and getting prepared for their wedding

While the oxytocin receptor variant, OXTR rs53576, has been previously studied and linked to personality traits such as emotional stability, empathy, and sociability, the new study is believed to be the first to examine its role in marital satisfaction.

“This study shows that how we feel in our close relationships is influenced by more than just our shared experiences with our partners over time,” said Monin. “In marriage, people are also influenced by their own and their partner’s genetic predispositions”.

The researchers also found that people with the GG genotype reported less anxious attachment in their marriage, which also benefitted their relationship. Anxious attachment is a style of insecured relationship that develops from past experiences with close family members and partners over the life course, and is associated with diminished self-worth, high rejection sensitivity, and approval-seeking behaviour, said Monin.

The researchers asserted that an individual’s GG genotype and their partner’s GG genotype together account for about 4 per cent of the variance of marital satisfaction. Although this percentage is small, it is a significant influence considering other genetic and environmental factors to which couples are exposed.

“This study shows that how we feel in our close relationships is influenced by more than just our shared experiences with our partners over time,” said Monin

“In marriage, people are also influenced by their own and their partner’s genetic predispositions”, the study found.

 

 

 

Which of the following statements refers to cholecalciferol:

4

Which of the following statements refers to cholecalciferol:

a) Frequent monitoring of both calcium and phosphorus serum levels is necessary in case of intravenous administration

b) Has potent anti-osteoclast activity – mechanism unknown

c) Can usually lower serum calcium levels in 48 hours

d) Mechanism of action: 1. Genomic effects 2. Cytoplasmic effects